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The development of nano-materials is viewed as one of the most important technolog-
ical advances of the 21st century and new applications of nano-sized particles in the
production, processing, packaging or storage of food are expected to emerge soon. This
trend of growing commercialization of engineered nanoparticles (NPs) as part of mod-
ern diet will substantially increase oral exposure due to their deliberate or accidental
incorporation in food. After oral uptake, NPs encounter dendritic cells (DCs), which
constitute first-line biological sensors of foreign materials invading the organism. These
specialized sentinel cells are necessary to launch immune reactions against pathogens but
also to mediate tolerance to self-antigens and, in the intestinal milieu, to nutrients and
commensals. A key question in the safety evaluation of orally ingested nanomaterials is,
therefore, whether their contact with DCs in the intestinal mucosa disrupts this delicate
homeostatic balance between pathogen defense and tolerance.
Here, we monitored the response of steady-state DCs exposed to food-grade synthetic
amorphous silica (SAS) to examine the potential ability of this common nanomaterial
to trigger adverse immune reactions. The differential display of molecular maturation
markers shows that SAS particles are able to activate completely immature, unprimed
DCs differentiated from hematopoietic progenitors. A concomitant internalization of
particles by endocytic uptake into the DCs fails to elicit cytotoxicity. However, this en-
docytic uptake of SAS particles leads to induction of the pro-interleukin-1β (pro-IL-1β)
cytokine precursor, subsequently cleaved by the inflammasome to secrete highly inflam-
matory IL-1β. In contrast, neither pro-IL-1β induction nor IL-1β secretion is triggered
upon internalization of TiO2 or FePO4 nanoparticles. Pharmacologic inhibitors of the
endosomal pathogen recognition process like chloroquine and bafilomycin A1 suppress
the observed pro-IL-1β induction, indicating that expression of this cytokine precur-
sor takes place in DCs because the nanostructured surface of SAS materials mimics a
microbe-associated molecular pattern.
This activation of immature DCs with a direct de novo induction of a potent inflamma-
tory cytokine, by a novel and unexpectedmechanism, implies that the currentlymassive
use of SAS materials as food additives should be reconsidered.
3
Zusammenfassung
Die Entwicklung von Nanomaterialien wird als eine der bedeutendsten Errungenschaf-
ten des 21. Jahrhunderts angesehen und neue Anwendungen von Nanopartikeln in der
Lebensmittelproduktion, -verarbeitung, -verpackung und -aufbewahrung werden in na-
her Zukunft erwartet. Durch diesen Trend wachsender Kommerzialisierung wird die
orale Exposition durch bewusste oder unbeabsichtigte Beimischung von synthetisch her-
gestellten Nanopartikeln (NP) in Lebensmitteln substanziell erhöht. Nach der oralen
Aufnahme treffen NP auf dendritischen Zellen (DC), die als biologische Alarmgeber
den Eintritt fremder Materialien überwachen. Diese spezialisierten Wächterzellen sind
notwendig, um einerseits effektive Immunantworten gegen Pathogene zu initiieren, und
andererseits um immunologische Toleranz gegenüber körpereigenen Antigenen und im
Darm zusätzlich gegenüber Nahrungsmitteln und nützlichen Kommensalen zu vermit-
teln. Eine Schlüsselfrage in der Sicherheitsbeurteilung von Nanopartikeln in Lebensmit-
teln lautet daher, ob ihr Kontakt mit DC in der intestinalen Schleimhaut dieses Gleich-
gewicht zwischen Abwehr und Toleranz beeinträchtigt.
In dieser Arbeit wurde daher die Reaktion von unreifen dendritschen Zellen auf syn-
thetisches amorphes Siliciumdioxid (SAS) getestet, um zu untersuchen, ob die dieses
Material unerwünschte Immunreaktionen hervorrufen kann. Veränderungen der mole-
kularenMaturationsmarker zeigen, dass SAS unreife, unstimulierte DC, die aus hämato-
poetischen Vorläuferzellen differenziert wurden, aktivieren kann. Die Partikel werden
bei diesem Prozess endosomal aufgenommen, lösen aber keine Zytotoxität aus. Aller-
dings wird durch diese endosale Aufnahme das Propeptid pro-Interleukin-1β (pro-IL-
1β) induziert, das anschliessend vom Inflammasom enzymatisch gespalten und als hoch-
entzündliches Zytokin IL-1β freigesetzt wird. Im Gegensatz dazu löste die Aufnahme
von TiO2 oder FePO4 Nanopartikeln weder pro-IL-1β Induktion noch Sektretion von
IL-1β aus. Pharmakologische Inhibitoren des endosomalen Mustererkennungssystems
wie Chloroquin und Bafilomycin A1 unterdrücken die pro-IL-1β-Induktion, was darauf
hinweist, dass das Propeptid pro-Interleukin-1β (pro-IL-1β) induziert wird, weil die na-
nostrukturierte Oberfläche von SAS-Materialien ein Pathogen-assoziiertes molekulares
Muster imitiert.
4 Zusammenfassung
Die Aktivierung von unreifen, unstimulierten DC mit direkter de novo Induktion eines
hochentzündlichen Zytokins – über einen neuartigen und unerwartetenMechanismus –
impliziert, dass der allgegenwärtige, verbreitete Einsatz von SAS-Materialien als Lebens-
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Although the respiratory toxicity of inhaled nanomaterials gained much attention (War-
heit &Donner, 2015; Yazdi et al., 2010), the gastrointestinal tract is exposed to compara-
bly much larger amounts of inorganic particles including nanostructured food additives
(Evans et al., 2002; Lomer et al., 2002; Winter et al., 2011; Yada et al., 2014). Silica
(silicon dioxide) has currently the highest production volume of all engineered nanoma-
terials worldwide (Yang et al., 2016). Common applications in the food industry use
synthetic amorphous silica (SAS) as anticaking agent in powdered food products (Fig-
ure 1), as defoaming agent in beverages, as a thickener in pastes or carrier of flavorings
(Dekkers et al., 2011; Peters et al., 2012). Titanium dioxide, containing up to 36% parti-
cles with a size below 100 nm, serves as a whitening agent in food and toothpastes (Weir
et al., 2012). New emerging uses in the food industry include FePO4 particles for iron
fortification (Hilty et al., 2010).
Figure 1. Food products containing nano-structured synthetic amorphous silica (SAS)
particles (E551) or titanium dioxide (E171) as a food additive. Several food products
containg the food additives E171 and/or E551 as ingredients are shown.
1.1 Nano-structured silica in food
Section 1.2 and a part of section 5 constitute part of a review article. I wrote the
manuscript together with H. Naegeli.
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Critical review of the safety assessment 
of nano-structured silica additives in food
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Abstract 
The development of nano-materials is viewed as one of the most important technological advances of the 21st 
century and new applications of nano-sized particles in the production, processing, packaging or storage of food are 
expected to emerge soon. This trend of growing commercialization of engineered nano-particles as part of modern 
diet will substantially increase oral exposure. Contrary to the proven benefits of nano-materials, however, possible 
adverse health effects have generally received less attention. This problem is very well illustrated by nano-structured 
synthetic amorphous silica (SAS), which is a common food additive since several decades although the relevant risk 
assessment has never been satisfactorily completed. A no observed adverse effect level of 2500 mg SAS particles/kg  
body weight per day was derived from the only available long-term administration study in rodents. However, 
extrapolation to a safe daily intake for humans is problematic due to limitations of this chronic animal study and 
knowledge gaps as to possible local intestinal effects of SAS particles, primarily on the gut-associated lymphoid 
system. This uncertainty is aggravated by digestion experiments indicating that dietary SAS particles preserve their 
nano-sized structure when reaching the intestinal lumen. An important aspect is whether food-borne particles like 
SAS alter the function of dendritic cells that, embedded in the intestinal mucosa, act as first-line sentinels of foreign 
materials. We conclude that nano-particles do not represent a completely new threat and that most potential risks 
can be assessed following procedures established for conventional chemical hazards. However, specific properties of 
food-borne nano-particles should be further examined and, for that purpose, in vitro tests with decision-making cells 
of the immune system are needed to complement existing in vivo studies.
Keywords: Aerosil, Corona, Dendritic cells, E 551, Food toxicology, Lymphoid tissue, Nanomaterial, SAS, Synthetic 
amorphous silica, Silicium dioxide
© 2016 The Author(s). This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/
publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Background
he use of nanotechnology has many potentially ben-
eicial applications in food production, processing and 
storage. he largest share of predicted markets involves 
nano-sized coatings of food-packaging materials that 
optimize mechanical properties or exert antimicro-
bial activity. In the future, nano-sized additives may be 
deliberately included to modify food properties such as 
taste, sensation, color, texture, consistency or shelf life, 
to fortify basic foods with nutrients and vitamins or to 
enhance bioavailability. An emerging application in the 
food industry includes, for example, the use of nano-Fe 
particles for iron supplementation. Nano-sized mate-
rials might further be employed as indicators of food 
quality and freshness, or to ensure traceability [1–3]. In 
contrast to these novel developments, nano-structured 
silica has been on the market as a food additive since 
around 50 years. In the United States, the Food and Drug 
Administration allows up to 2 % by weight of such silica 
particles to be added to food [4]. Within the European 
Union (EU), Commission Regulation 1129/2011 sets a 
maximum level for silica of 1 % by weight in dried pow-
dered foodstufs [5]. Silica particles may thus be regarded 
as a paradigmatic case for the safety assessment of nano-
material applications in the food industry.
A European Commission Recommendation deines 
nano-materials as having one dimension not exceeding 
100 nm [6]. However, there is no solid scientiic ground 
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to propose a strict size boundary and the preix “nano” 
does not make a substance automatically harmful. Nev-
ertheless, the nano-size scale changes the material char-
acteristics as compared to larger particles or the same 
substance in a dissolved state. Nano-sized materials dis-
play an increased surface-to-mass ratio that enhances 
their reactivity compared to larger structures [7, 8]. Also, 
nano-sized particles easily penetrate intact cell mem-
branes thus conferring the potential for traicking across 
biological barriers including the epithelium of the gas-
trointestinal tract [9–13]. Until now, the health efects of 
nano-particles have been studied mainly in relation to a 
respiratory uptake [14]. Considering their widespread 
food-related uses, however, there is an urgent need to 
review the suitability of oral toxicity and risk assessment 
studies addressing the long-term safety of nano-struc-
tured silica.
Synthetic amorphous silica
Silicon (Si) is a metalloid displaying an atomic weight 
of 28. he terms “silicium” and “silica” refer to naturally 
occurring or anthropogenic materials composed of sili-
con dioxide (SiO2), which appears in two major forms, 
i.e., crystalline and amorphous. Synthetic amorphous 
silica (SAS) is widely applied to processed foods and 
registered by the EU as a food additive with the code 
E 551 [15]. he main purpose of SAS particles in the food 
industry is to prevent poor low or “caking”, particularly 
in powdered products. SAS particles are additionally 
employed as a thickener in pastes or as a carrier of la-
vors, and also to clarify beverages and control foaming 
[16–18].
Silica particles exist in large amounts in nature and it 
is acknowledged that that they have been dietary con-
stituents throughout human evolution. However, the risk 
assessment of silica discussed in this review is limited 
to man-made materials introduced as food additives. In 
1942, Harry Kloepfer (a chemist working at Degussa, now 
Evonik) invented the Aerosil procedure for the produc-
tion of SAS particles intended for the food industry [19, 
20]. Following a standard pyrogenic process, also known 
as lame hydrolysis, silicon tetrachloride is burned in a 
hydrogen lame at temperatures of 1000–2500  °C, gen-
erating silica nano-particles with a diameter of ~10  nm 
[21]. his material is denoted pyrogenic or fumed silica 
referring to the above production method. In an alterna-
tive wet route of synthesis, nanostructured SAS parti-
cles denoted as precipitated silica, silica gel or hydrous 
silica, are produced from alkali metal silicates dissolved 
in water and reacted with sulphuric acid. In the EU, only 
synthetic particles obtained by these pyrogenic or wet 
processes are allowed as food additive [15]. All SAS prod-
ucts aggregate into larger particles with sizes in the order 
of 100  nm, which further agglomerate to form micron-
sized structures [14, 22]. he term “aggregate” describes 
an assembly of particles held together by strong forces 
such as covalent or metallic bonds. “Agglomerates” of 
particles appear as a consequence of weak forces like van 
der Waals interactions, hydrogen bonding, electrostatic 
attractions or adhesion by surface tensions. SAS mate-
rials are hydrophilic but can be rendered hydrophobic, 
thus reducing their moisture uptake, by subsequent sur-
face modiications.
Oral toxicity studies using SAS particles
A synopsis of animal studies addressing the oral safety of 
SAS particles was published by the European Centre for 
Ecotoxicology and Toxicology of Chemicals (ECETOC) 
[23] and, more recently, by the Organization for Eco-
nomic Co-operation and Development (OECD) [24]. No 
mortality or adverse signs resulted from acute exposure 
by single oral administrations of hydrophilic SAS par-
ticles to rodents at doses of up to 5000 mg per kg body 
weight. A sub-acute (28-day) study was carried out by 
oral gavage administration of hydrophilic SAS particles 
to Wistar rats. he daily doses ranged between 100 and 
1000  mg/kg body weight. None of the monitored end-
points (clinical signs, food consumption, body weight, 
behavioral tests, hematology, clinical chemistry param-
eters, organ weights, macroscopic pathology and his-
tological examinations) revealed any substance-related 
abnormalities [25].
In a sub-chronic (90-day) toxicity study carried out in 
Charles River rats with daily doses of up to 3500 mg/kg 
body weight, hydrophilic SAS particles included in the 
feed did not elicit systemic toxicity and did not afect 
growth rate, food consumption or survival [26]. Also, no 
macroscopic or microscopic changes were observed in 
post-mortem analyses of the organs of exposed animals. 
A more detailed 90-day toxicity study was conducted in 
Wister rats with in-diet administrations of hydrophilic 
SAS particles (up to 4000 mg/kg body weight daily). End-
points included general condition and survival, behavior, 
water intake, food consumption, body weight, hematol-
ogy, clinical chemistry, urinary analysis, organ weights, 
macroscopic pathology and histological examinations. 
As observed in the previous sub-chronic study, none of 
these parameters revealed any efects ascribed to SAS 
ingestion [27]. Sub-chronic dietary exposure studies were 
also carried out with hydrophobic SAS particles not per-
mitted as food additive in the EU. In one case [28], no 
treatment-related abnormalities were reported except 
minimal changes in the thyroid gland morphology of 
male rats exposed to 2000 and 4000 mg/kg body weight 
daily. In another repeated dose toxicity study with hydro-
phobic SAS particles [29, 30], Wister rats were exposed 
10 Introduction
Page 3 of 9Winkler et al. J Nanobiotechnol  (2016) 14:44 
via the diet for 5  weeks at 0 (control), 500 or 1000   
mg/kg body weight per day, and for 8 weeks at progres-
sively increasing SAS doses from 2000 to 16,000  mg/kg 
body weight per day. Animals in these high-dose group 
developed severe atrophy of the liver detected by micro-
scopic examination, which was also observed to a milder 
degree in the 1000-mg/kg dose group.
Further efects on the liver were described in more 
recent reports, thus converging on a potential systemic 
hazard of SAS particles (Table  1). In one repeated oral 
toxicity study, BALB/c mice were exposed for 10  weeks 
to hydrophilic nano- or micron-sized silica particles 
prepared from rice husk (not permitted as food additive 
in the EU) [31]. he inclusion rate in feed was 1 % (wt/
wt) translating to an expected oral uptake of 1500  mg/
kg body weight per day. he animal group fed the nano-
particles showed a signiicantly higher serum level of 
alanine aminotransferase (a biomarker of liver injury) 
compared to untreated controls or animals tested with 
micro-sized silica. In the histologic examination of tis-
sues from mice exposed to nano-particles, but not in 
those exposed to micro-particles, there was an appear-
ance of fatty liver characterized by abnormally frequent 
lipid droplets in hepatocytes. Further liver reactions were 
detected in a repeated dose toxicity study in Sprague–
Dawley rats [32]. he animals were exposed via feed to 
hydrophilic SAS particles obtained from Evonik (denoted 
“Evonik-SAS”) or from the Joint Research Centre of the 
European Commission (denoted “JRC-SAS”). Both mate-
rials were produced by lame hydrolysis but difered in 
their surface area, i.e., 380 and 200 m2/g for “Evonik-SAS” 
and “JRC-SAS”, respectively. hese particles were deliv-
ered with the feed at diferent daily doses (between 100 
and 2500  mg/kg body weight) for 28  days, whereby the 
exposure was extended to 84  days for the highest dose 
groups. No treatment-related efects were observed after 
28  days. However, following 84  days of exposure, the 
occurrence of periportal liver ibrosis was higher than in 
control animals (Table 1). his increase in the frequency 
of liver ibrosis was signiicant in the JRC-SAS-treated 
animals (p  =  0.02) but slightly below statistical signii-
cance (p  =  0.07) in the Evonik-SAS-treated group. he 
histological efects were not accompanied by changes in 
clinical chemistry. Notably, this experiment also included 
some immunological parameters like IgG and IgM levels 
in blood, lymphocyte proliferation, as well as cytokine 
release from in vitro activated lymphocytes. None of the 
tested immunological endpoints were afected in any of 
the dose groups.
Long-term dietary studies in rats [33] were used for 
the risk assessment of human exposure. Groups of 40 
Fischer rats were fed 0 (control), 1.25, 2.5 and 5 % (wt/wt) 
hydrophilic SAS particles for 103 consecutive weeks. he 
design of this chronic bioassay is outlined for the high-
dose group in Table  2. he feed was not examined for 
possible nutritional imbalances [34]. here were no test 
substance-related efects on food consumption, overall 
survival, clinical laboratory or hematologic results and 
microscopic pathology indings. Liver weights were sig-
niicantly reduced in the females fed 2.5 and 5 % SAS par-
ticles and this efect might be a consequence of the lower 
body weight attained in these two higher dose groups 
relative to controls and animals in the 1.25  % inclusion 
group. It is retrospectively not possible to distinguish 
whether the efect on liver weight represents an adverse 
reaction to SAS ingestion or whether it is an indirect 
consequence of a possible nutritional imbalance not 
directly related to SAS exposure. Notably, SAS-treated 
males displayed isolated cases of hyperplastic nodules in 
the liver and pheochromcytomas in the adrenal gland, 
but none of the control animals had such rare lesions. 
A long-term study in B6C3F1 mice involved groups 
of 40 animals fed 0 (control), 1.25, 2.5 and 5  % (wt/wt) 
SAS particles for 93 weeks [33]. Again, the feed was not 
examined for nutritional imbalances. he growth rate 
was signiicantly reduced in the mice of the high-dose 
group only at the end of the irst 10 study weeks. Food 
consumption was signiicantly increased in the males fed 
2.5 and 5 % SAS particles but no other substance-related 
diferences came to light. he treatment had no efect on 
clinical chemistry, hematologic results and macroscopic 
as well as microscopic pathology indings. Recently, the 
European Commission Scientiic Committee on Con-
sumer Safety pointed out that these long-term studies 
Table 1 Oral repeated dose toxicity studies with amorphous silica yielding liver efects
Delivery of particles was by inclusion into the feed. This table proposes LOAEL (lowest observed adverse efect level) and NOAEL (no observed adverse efect level) 
values that difer from those purported in previous risk assessment reports. Other oral repeated dose studies [25–27] did not elicit adverse efects
Species Study length Efect LOAEL NOAEL Reference
Wistar rats 5–8 weeks Liver atrophy 1000 mg/kg body weight per day 500 mg/kg body weight per day [29, 30]
Balb/c mice 10 weeks Fatty liver 1500 mg/kg body weight per day NA [31]
Sprague–Dawley rats 12 weeks Periportal liver fibrosis 810 mg/kg body weight per day NA [32]
Fischer rats 103 weeks Reduced liver weight 1000 mg/kg body weight per day 500 mg/kg body weight per day [33]
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in rodents cannot be considered as adequate for risk 
assessment because it is not clear whether the research 
was conducted under generally accepted guidelines and 
because the test material was not properly described [35].
To summarize, a critical analysis of existing oral 
repeated dose studies in rodents reveals data gaps and 
uncertainties limiting their predictive value for the risk 
assessment of human dietary exposure. Some studies 
were based on poorly characterized particles in terms of 
composition, impurities or physico-chemical properties, 
and most reports lacked an assessment of particle size 
distribution.
Oral bioavailability and systemic distribution
Little is known on the intestinal absorption of nano-sized 
SAS particles and the potential to disseminate into tis-
sues. A limited systemic uptake following oral inges-
tion cannot be ruled out although none of the tested 
SAS particles were shown to bio-accumulate [19]. his 
is illustrated by a repeated dose kinetic study, in which 
rats were administered SAS particles via gavage at a low 
dose of 20 mg/kg body weight during 5 consecutive days 
[36, 37]. On the sixth day of the study, measurements by 
quadrupole inductively coupled plasma mass spectrome-
try (ICP-MS) revealed only slightly elevated silicon levels 
in liver and spleen. he gastrointestinal absorption after 
administration of SAS particles, estimated from these 
silicon measurements in tissues and not considering a 
concurrent excretion, ranged between 0.03 and 0.06 % of 
the total oral dose [38]. In another repeated dose study 
already presented above, rats were administered SAS 
particles via feed for 28  days, with continued adminis-
tration in the high-dose group for up to 84 days. Silicon 
contents were measured at days 29 and 84 by ICP-MS in 
liver, spleen, kidney, brain and testis. Conversion of the 
resulting silicon levels to assumed silica concentrations 
in tissues, again not considering concomitant excre-
tion processes, indicated an overall oral bioavailability of 
0.02  % or less [32]. he highest silica concentration (up 
to ~300  mg/kg tissue against a physiologic background 
below the limit of detection) was found in the spleen of 
SAS-exposed animals. So far, no SAS particles have been 
detected in mesenteric lymph nodes or any other organ 
after oral uptake and, therefore, it is not clear whether 
the observed silicon residues exist in a particulate form 
or rather in a dissolved state, for example as orthosilicic 
acid.
Another key issue that has not yet been investigated 
with regard to bioavailability and systemic distribution 
is the efect of biomolecules bound to nano-particles 
changing their surface properties [38]. In particular, SAS 
nano-particles are known to be decorated by proteins, for 
example ibrinogen or apolipoprotein A1, as soon as they 
get in contact with biological luids [39]. he term “pro-
tein corona” was introduced to describe the attachment 
of plasma proteins to the surface of nano-particles [40, 
41]. One possible efect of this corona is that it mediates 
the uptake of nano-particles into cells and organs includ-
ing the liver, thus inluencing bioavailability and tissue 
distribution [42].
Human exposure
To obtain realistic dietary exposure values for a European 
population, Dekkers and colleagues [18] selected food 
products from a local supermarket (ready-to-eat meals, 
soups, sauces, cofee creamers, pancake mixes, season-
ings and supplements) based on declarations for the 
presence of E 551. Next, the total silica concentration in 
these products was determined by inductively coupled 
plasma atomic emission spectrometry (ICP-AES). hen, 
dietary intake estimates of these products for the popu-
lation were calculated using a Dutch food consumption 
survey [43]. Based on estimated consumption and silica 
levels, the resulting daily dietary intake was 9.4 mg SAS 
particles per kg body weight. his total daily quantity 
includes all SAS particles regardless of their degree of 
aggregation or agglomeration. Hydrodynamic chroma-
tography with inductively coupled plasma mass spec-
trometry (HDC-ICPMS) showed that up to ~40 % of SAS 
particles detected in food products display an external 
diameter <200 nm [18].
he next question was whether the SAS particles 
in commercial food products would be destroyed in 
the digestive tract or rather withstand gastrointestinal 
Table 2 Outline of the chronic toxicity study with SAS particles carried out in rats
Summarized data from the oral chronic toxicity study in Fischer rats [33]. This table illustrates the relationship between body weight, feed intake and daily doses in the 
females of the highest dose group, where the feed was supplemented with 5 % (wt/wt) SAS particles. When corrected for the actual feed intake, the daily dose of SAS 
particles was between 1.8 and 2.0 g/kg body weight during most of the study period
Weeks of feeding
0 5 15 30 50 81 103
Body weight (g) 108 ± 6 174 ± 9 223 ± 11 253 ± 10 310 ± 18 364 ± 26 359 ± 56
Feed intake (g/day) 11.1 ± 0.4 10.4 ± 0.4 10.2 ± 0.5 11.9 ± 0.8 13.2 ± 0.8 12.7 ± 2.7
SAS intake (g/kg body weight per day) 3.2 2.3 2.0 1.9 1.8 1.8
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conditions. Using an in  vitro system mimicking human 
gastric digestion, it could be demonstrated that nano-
structured silica forms agglomerates under acidic condi-
tions resembling the milieu of the stomach. By switching 
the conditions to those imitating the subsequent intes-
tinal digestion stage, however, these large agglomerates 
disintegrate readily into nano-sized silica structures. In 
light of these in vitro indings, it was concluded that up 
to ~80 % of orally ingested SAS particles withstand gas-
tric dissolution and display a nano-sized range once they 
reach the intestinal lumen [44].
Inadequacies of existing risk assessments
Nano-particles are neither inherently toxic nor inher-
ently safe and possible adverse efects should be tested 
case-by-case. In principle, a standard assessment with 
risk =  hazard ×  exposure, which includes hazard iden-
tiication, hazard characterization, exposure assessment 
and risk characterization, is applicable to nano-materials 
in food [21, 45, 46].
he United Kingdom Food Standards Agency Expert 
group on Vitamins and Minerals (EVM) performed an 
assessment of the oral safety of SAS particles, yielding a 
safe upper dietary level for daily consumption of 1500 mg 
SAS particles per day for adults [34]. his upper safety 
limit was calculated from the only available long-term 
toxicity study in rats [33], despite its limitations recently 
reiterated by the Scientiic Committee on Consumer 
Safety [35]. he EVM experts noted that oral exposure to 
SAS particles for 103 consecutive weeks elicited efects 
on body weight and absolute liver weight (concerning the 
groups with a 2.5 and 5 % dietary inclusion rate). How-
ever, they attributed this outcome to possible nutritional 
imbalances, not adjusted in these two higher dose groups 
and considered unlikely to be relevant for humans. 
On this basis, the EVM group concluded that the no 
observed adverse efect level (NOAEL) is equivalent to 
the highest dose tested, i.e. 5 % SAS (wt/wt) in the diet. 
In the absence of further information or studies explain-
ing the reduction in body and liver weight, we advocate a 
more cautious approach by deriving from the same study 
a lower NOAEL equivalent to the 1.25 % inclusion rate, 
also in view of the emergence of liver hyperplastic nod-
ules and adrenal pheochromcytomas recorded in a few 
SAS-treated males but never in controls [33]. his more 
cautious interpretation is supported by a recent, above-
described study [32] revealing periportal liver ibrosis in 
SAS-exposed rats.
As indicated, the EVM expert group opted for a 
NOAEL of 5  % dietary inclusion and further estimated 
that this translates by default to a daily dose of 2.5 g/kg 
body weight. After introducing an uncertainty factor of 
100 (to adjust for inter-species as well as inter-individual 
variations in sensitivity), the derived safe upper level for 
lifetime daily consumption of SAS particles was 25 mg/
kg per day, equivalent to 1500  mg per day for a 60-kg 
adult. In terms of elemental silicon, the “safe” upper limit 
for daily consumption is 12 mg/kg body weight per day 
(equivalent to 700 mg for a 60-kg adult). In 2004, the Sci-
entiic Panel on Dietetic Products, Nutrition and Aller-
gies (NDA Panel) at the European Food Safety Authority 
concluded for silicon that “there are no suitable data for 
dose—response for establishment of an upper level” [47]. 
In 2009, however, the Scientiic Panel on Food Additives 
and Nutrient Sources added to Food (ANS Panel) took 
into consideration the risk assessment carried out by the 
EVM experts and adopted their proposed upper limit of 
1500 mg per day when assessing silicon dioxide as food 
additive [46]. It remains to be mentioned that default 
intake calculations made by translating a 5 % inclusion in 
the feed of rats to an assumed ingestion of 2.5 g/kg per 
day seem incorrect as the actual daily dose of SAS parti-
cles, determined from feed consumption in the high-dose 
group, was around 1.9 g/kg body weight during most of 
the study period (Table 2). Similarly, the lower inclusion 
rates of 1.25 and 2.5  % correspond to daily oral doses 
of around 0.5 and 1  g/kg, respectively. To summarize, 
several gaps in both study design and interpretation of 
results diminish the predictability of the only available 
long-term bioassays in rodents addressing the oral safety 
of SAS particles.
Potential for local efects in the gastrointestinal 
tract
Depending on the nature of identiied hazards that raise 
concerns, the canonical risk characterization may need 
to be complemented with endpoints that are not rou-
tinely assessed in the toxicological evaluation of chemi-
cals. For example, a nano-Trojan horse hypothesis has 
previously been proposed in view of the observation 
that, in human lung epithelial cells exposed to Co3O4 or 
Mn3O4 nano-particles, the generation of reactive oxygen 
species (ROS) was higher than in controls exposed to 
an equivalent concentration of dissolved cobalt or man-
ganese salts [10]. It is equally conceivable that the bind-
ing of luminal antigens to SAS particles could aid their 
delivery to reactive cells of the gastrointestinal tract. In 
this respect, we note in particular that none of the above-
reviewed studies examined local efects on the lymphoid 
tissue of the gastrointestinal mucosa. Rather than causing 
ROS production, SAS particles have been implicated in 
the release of pro-inlammatory cytokines (see below).
Although the function of the immune system is to 
safeguard the host against invasive pathogens, the 
steady-state gastrointestinal tract is geared towards 
immune silencing or tolerance to avoid futile reactions 
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to innocuous food antigens and beneicial commensal 
microorganisms [48, 49]. Upon oral exposure, foreign 
particles encounter a single layer of mucous membrane 
lining the digestive tract. his large vulnerable surface is 
defended by the gut-associated lymphoid tissue, which 
consists of loosely organized clusters of lymphoid cells 
and more organized Peyer’s patches. Nano-particles 
including those made of silica are known to penetrate this 
lymphoid tissue underlying the epithelial barrier [50–53], 
where they may disrupt the critical balance between tol-
erance to harmless food constituents and commensals 
on the one hand and inlammatory reactions towards 
pathogens on the other hand [54, 55]. Speciic analy-
ses of Peyer’s patches are not mentioned in the available 
sub-chronic and chronic toxicity studies in rodents and, 
therefore, it is not possible to ascertain whether delayed 
local efects on the gut-associated lymphoid system were 
adequately excluded.
Previous studies highlighted the fact that there is one 
critical site in which food-borne nano-particles accumu-
late during lifelong exposure, i.e., in “pigment cells” of the 
gut-associated lymphoid tissue where the earliest signs of 
inlammatory bowel disease (IBD) are noted (reviewed in 
[56–58]). his is a wide group of chronic conditions rang-
ing from Crohn’s disease (afecting all segments of the 
digestive tract) to ulcerative colitis (restricted to the large 
bowel, [59]). he main gatekeepers of tolerance in the 
intestinal system, as well as major mediators of adverse 
reactions like IBD, are specialized antigen-presenting 
cells known as dendritic cells [60]. hey act as scavengers 
of foreign materials by extending branched and rapidly 
changing projections across the epithelial barrier into the 
gut lumen and taking up particles by endocytosis [61]. 
Particles are also delivered directly to dendritic cells after 
their passage through microfold cells (M-cells) in the 
intestinal mucosa. In this way, dendritic cells ilter out a 
volume of up to 1500  µm3, which equals their own cell 
volume, per hour [62]. Unlike other antigen-presenting 
cells, dendritic cells constitutively express class II major 
histocompatibility complexes and, in response to patho-
gen recognition, display co-stimulatory surface glyco-
proteins and produce inlammatory cytokines. For these 
reasons, dendritic cells constitute potent activators of the 
innate immune system and also polyvalent drivers of T 
lymphocytes [63, 64]. As nano-particles are in the same 
size range as many proteins or common viruses, it is not 
surprising to ind that, by virtue of their function in prob-
ing the environment for intruding insults, dendritic cells 
capture nano-particles in an eicient manner [65–67].
It was shown that endotoxin-activated dendritic 
cells release the potent pro-inlammatory cytokine 
interleukin-1β (IL-1β) upon incubation with SAS nano-
particles [68]. Mechanistically, this response has been 
linked to activation of the inlammasome complex, which 
in turn cleaves the pro-IL-1β precursor protein to release 
active IL-1β. In view of this inding, it will be of pivotal 
importance to determine how steady-state dendritic cells 
like those residing in the normal non-inlammatory intes-
tinal mucosa react to the presence of food-borne SAS 
particles. IBD has a multi-factorial origin with genetic 
susceptibility, gut microlora and a dysfunction of the 
mucosal immune system as main drivers [60]. Addition-
ally, various dietary factors have been implicated in the 
increasing incidence of IBD and several authors raised 
the concern that food-borne nano-particles may con-
tribute to initiating this chronic inlammatory disease 
[69–71]. Inadvertent stimulation of the immune system 
by nano-particles could trigger a reaction sequence that 
abrogates tolerance to food constituents and commensal 
bacteria and thereby favor immune-mediated conditions 
with the hallmarks of IBD (reviewed by [72]).
Conclusions
Previous and current controversies on hormone or anti-
biotic residues in food illustrate that nutrition is a highly 
emotional area in the public perception. he inding that 
SAS particles activate the inlammasome and, hence, are 
not biologically inert is intriguing because this type of 
nano-structured material has been employed since dec-
ades as food additive and is so far considered to be safe 
for consumers. Based on a critical review of existing oral 
toxicity studies, however, we consider that adverse efects 
from food-borne SAS particles cannot be excluded. 
Table  1 summarizes independent repeated dose stud-
ies that reached much the same conclusion with an 
oral NOAEL of 500  mg per kg body weight and a low-
est observed adverse efect level (LOAEL) in the range of 
810–1500  mg per kg body weight. herefore, we advo-
cate a prudent approach by taking the oral NOAEL of 
500 mg/kg, based on body and liver weights in the 103-
week feeding study in rats, as point of departure for the 
risk assessment of SAS particles. his NOAEL is lower 
than previously proposed [34] but, as summarized in 
Table  1, is consistent with the outcome (liver atrophy) 
of a 8-week feeding study and the liver efects (peripor-
tal ibrosis) in a 12-week feeding study, both in rats, at 
daily doses of 810–1000 mg/kg body weight. By applying 
a default uncertainty factor of 100 (to adjust for inter-
species and inter-individual variations in sensitivity), this 
NOAEL would yield a safe upper level for the lifetime 
intake of SAS particles of 5 mg/kg body weight per day. 
he estimated consumption by a European population 
of 9.4 mg per kg body weight and day would, therefore, 
suggest that the dietary exposure to SAS particles should 
be reduced to remain, even with a worst case exposure 
scenario, below this newly proposed safety threshold of 
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5 mg/kg daily. Importantly, further studies are needed to 
investigate local efects of SAS particles in the gastroin-
testinal system, particularly on the gut-associated lym-
phoid tissue and embedded dendritic cells. In a broader 
perspective, mechanistic in vitro studies at diferent lev-
els of biological complexity are necessary to understand 
in depth how food-borne nano-particles may inluence 
the delicate balance between immune tolerance and 
inlammatory responses that depends on the proper 
function of dendritic cells in the intestinal mucosa. his 
research direction is crucial to eventually address the 
concern that the higher occurrence of IBD may be in part 
a consequence of the lifelong ingestion of nano-sized or 
nano-structured food additives increasingly used in the 
modern diet.
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1.2 Titanium dioxide as food additive
Titanium dioxide TiO2 anatase is widely used as a white pigment. As a common food
additive, it’s used since several decades and labelled E171. Food products with E171
were found to contain a nano-sized fraction of TiO2 particles (Weir et al., 2012). In
humans, titanium dioxide particles were shown to be present in the blood within hours
after oral administration of food-grade E171 (Pele et al., 2015). Studies in mice have
shown that after intratracheal instillation of TiO2, especially anatase particles could
lead to chronic inflammation (Park et al., 2009). In mouse dendritc cells, primed with
lipopolysacharides (LPS), TiO2 particles were able to activate the inflammasome with
secretion of IL-1β (Winter et al., 2011). Therefore, we included food-grade TiO2 anatase
particles, and TiO2 anatase nanoparticles in the initial screening with steady-state DCs
to examine the potential ability of this material to trigger IL-1β secretion.
1.3 Iron (III) phosphate for food fortification
Food fortification with iron phosphate nanoparticles (FePO4) NPs could be used in
order to reduce iron deficiency and alleviate anemia, because these NPs have a high
bioavailability combined with an improved sensory performance (Hilty et al., 2010).
In this study, we monitored the response of steady-state DCs exposed to FePO4 to ex-
amine the potential ability of this nanostructured material to trigger adverse immune
reactions.
1.4 Immunity
Protection of a host against foreign materials and maintenance of tolerance towards
nutrients, food antigens and beneficial commensals is crucial for survival. The verte-
brate immune system achieves this with three layers: 1. a mechanical/physical barrier
working continuously, 2. innate immunity that reacts within hours and 3. adaptive im-
munity to target invaders specifically within several days. To avoid pathogenic insults,




Dendritic cells (DCs) develop from hematopoietic progenitors of the bone marrow un-
der the direction of felineMcDonough sarcoma-like tyrosine kinase 3 ligand (Scott et al.,
2014). This growth factor is required to generate steady-state DCs that, under homeo-
static conditions, reside in lymphoid organs like spleen and migrate to non-lymphoid
organs including skin, lung and intestines (Watowich & Liu, 2010; Shortman & Naik,
2007). In the Peyer’s patches ofmice, several subsets of dendritic cells have been found in-
cluding conventional DC (cDC), defined by the expression of CD11c+B220-CD11bhigh
SIRPα+ or CD11c+ B220-CD11bintermediateSIRPα- and plasmacytoid DC (pDC), which
are expressing the surface markers CD11cintermediateB220+ (Castellaneta et al., 2004). Stea-
dy-state DCs are dispersed throughout the mucosa of the intestinal tract where, in their
dual antigen-presenting role, these specialized sentinel cells initiate immune reactions in
response to pathogenic agents while maintaining tolerance to self-antigens, innocuous
food constituents and the beneficial microbiome (Bekiaris et al., 2014; Bogunovic et al.,
2009; Varol et al., 2009). As immature DCs in the periphery, they are characterized by
their high endocytic activity (Sallusto et al., 1995). Intestinal DCs extend branched and
rapidly changing projections across the epithelial barrier into the gut lumen and take
up particles. Particles are also delivered directly to dendritic cells after their passage
through microfold cells (M-cells) into the Peyer’s patches (Rescigno, 2009).
Figure 2. Hypothesis: NPs could disrupt the balance between defense and and toler-
ance upon internalization in immature DCs. After uptake of NPs, immature DCs may
become activated. Presentation of encountered antigen fragments at their cell surface on
MHC class II molecules (signal 1) together with up-regulated co-stimulatory cell-surface re-
ceptors for T-cell activation such as CD80, CD86 and CD40 (signal 2). In addition, DCs
may secrete pro-inflammatory cytokines (signal3฀).
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As specialized antigen presenting cells, DCs are equipped with a plethora of innate
pattern recognition receptors (PRRs) such as toll-like receptors (TLRs) and nucleotide-
binding oligomerization domain (NOD)-like receptors. TLRs recognize specific chemi-
cal motifs found on foreign pathogens. TLR2 and TLR4 for example detect LPS, while
TLR3, TLR7 and TLR9 are known to detect DNA motifs (Pandey et al., 2015). Upon
encountering foreign materials, immature DCs become activated (Figure 2) and migrate
as mature DCs to the lymph nodes. There, they present encountered antigen fragments
at their cell surface usingMHC class II molecules (Signal 1) together with co-stimulatory
cell-surface receptors for T-cell activation such as CD80, CD86 and CD40 (Signal 2).
In addition, DCs secrete cytokines, which are required for efficient immune responses
(Signal 3). We therefore monitored the response of DCs upon contact with food-grade
nanomaterials to examine the potential ability of thismaterial to trigger adverse immune
reactions.
20
2 Aim of the project
Despite the comparably high oral exposure of consumers with food-borne nanoparticles
and increasing applications of nanomaterials for food, no in-vitro test system to assess
the risk of food-borne nanomaterials on intestinal immunity is available.
Therefore, the aim of this thesis was to investigate the effects of food-borne nanoma-
terials on dendritic cells in-vitro. We thus set out to investigate whether nanoparticles
interact with steady-state dendritic cells and if this interaction leads to functional impli-
cations.
After in depth characterization of the food-grade nanoparticles, we generated imma-
ture dendritic cells from mouse bone marrow cultures supplemented with Flt3L. These
cells were analyzed by flow cytometry to determine their surface markers. After in-
cubation of the dendritic cells with different nanoparticles, interaction and uptake of
nanoparticles were studied by flow cytometry and transmission electron microscopy,
respectively.
To determine the consequences of the particle internalization observed, functional as-
says were conducted. DC were incubated with nanoparticles and analysed for changes
in activation and maturation markers. In addition, pro-inflammatory cytokine secre-
tion was monitored in the cell culture supernatant. The mechanism of particle internal-
ization was further delineated using pharmacological inhibitors. This inhibitor effects
supported the conclusion that the IL-1β response requires intracellular uptake of SAS
particles.
The finding, that pristine SAS particles are able to induce the secretion of IL-1β from
immature DCs prompted further experiments addressing the mechanism of pro-IL-1β-
induction and IL-1β secretion. These experiments with caspase inhibitors, inhibitors
of endosomal acidification and DCs lacking TLR2, TLR3, TLR4, TLR7 and TLR9 pro-




3.1 Interleukin-1β induction in immature dendritic cells
exposed to food-grade synthetic amorphous silica
This paper describes the the pro-inflammatory effects of food-grade SAS particles on
immature dendritic cells. We showed that SAS internalization in immature DCs is
sufficient to cause induction of the highly pro-inflammatory pro-interleukin-1β and
subsequent cleavage and secretion of interleukin-1β . I designed, performed and ana-
lyzed the experiments, prepared all figures and co-wrote the manuscript together with
H. Naegeli.
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Abstract
Background: Dendritic cells (DCs) constitute first-line sensors of foreign materials in-
vading the organism. These specialized sentinel cells launch immune reactions against
pathogens but also mediate tolerance to self-antigens and, in the intestinal milieu, to
nutrients and commensals. A key question in the evaluation of orally ingested nanoma-
terials is, therefore, whether their contact with DCs in the intestinal mucosa disrupts
this delicate homeostatic balance between pathogen defense and tolerance. Here, we
generated steady-state DCs by incubating haematopoietic progenitors with feline Mc-
Donough sarcoma-like tyrosine kinase 3 ligand (Flt3L) and used the resulting immature
DCs to test potential biological responses to food-grade synthetic amorphous silica (SAS)
representing a common nanomaterial.
Results: The interaction of completely immature and unprimedDCswith SAS particles
and their internalization by endocytosis fails to elicit cytotoxicity and does not trigger
the release of interleukin (IL)-1α or tumor necrosis factor-α, which have been recog-
nized as master regulators of acute inflammation in lung-related studies. However, the
display of molecular maturation markers on the cell surface shows that SAS particles are
able to activate immature DCs. Also, the endocytic uptake of SAS particles into these
steady-state DCs leads to induction of the pro-IL-1β cytokine precursor, subsequently
cleaved by the inflammasome to secrete highly inflammatory IL-1β . In contrast, nei-
ther pro-IL-1β induction nor IL-1β secretion occurs upon internalization of TiO2 or
FePO4 nanoparticles. Pharmacologic inhibitors of the endosomal pathogen recognition
pathway like chloroquine and bafilomycin A1 suppress the observed pro-IL-1β induc-
tion, indicating that expression of this cytokine precursor takes place in DCs because
the nanostructured SAS surface mimics a microbe-associated molecular pattern.
Conclusions: This activation of completely immature DCs with a direct de novo induc-
tion of a potent inflammatory cytokine, by an unprecedented and unexpected mecha-
nism, implies that the currently massive use of SAS materials as food additives should
be reconsidered.
KEYWORDS
E 551, food additive, food toxicology, gut-associated lymphoid tissue, inflammatory
bowel disease, nanomaterial, silicon dioxide
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Background: Dendritic cells (DCs) develop from hematopoietic progenitors of the
bone marrow under the direction of feline McDonough sarcoma-like tyrosine kinase
3 ligand (Flt3L, Additional file 1: Figure S1). This growth factor is required to gen-
erate steady-state DCs that, under homeostatic conditions, reside in lymphoid organs
like spleen and migrate to non-lymphoid organs including skin, lung and intestines
(Watowich & Liu, 2010; Shortman & Naik, 2007). Steady-state DCs are dispersed
throughout the mucosa of the intestinal tract where, in their dual antigen-presenting
role, these specialized sentinel cells initiate immune reactions in response to pathogenic
agents while maintaining tolerance to self-antigens, innocuous food constituents and
the beneficial microbiome (Bogunovic et al., 2009; Varol et al., 2009). Although the
respiratory toxicity of inhaled nanomaterials gained much attention (Warheit & Don-
ner, 2015; Yazdi et al., 2010), the gastrointestinal tract is exposed to comparably much
larger amounts of inorganic particles including nanostructured food additives (Evans
et al., 2002; Lomer et al., 2002; Winter et al., 2011; Yada et al., 2014). Silica has cur-
rently the highest production volume of all engineered nanomaterials worldwide (Yang
et al., 2016). Common applications in the food industry use synthetic amorphous silica
(SAS) as anticaking agent in powdered food products, as defoaming agent in beverages,
as a thickener in pastes or carrier of flavorings (Dekkers et al., 2011; Peters et al., 2012).
Titanium dioxide, containing a minor proportion of particles with a size below 100 nm,
serves as a whitening agent in food and toothpastes (Weir et al., 2012). New emerg-
ing uses in the food industry include FePO4 particles for iron fortification (Hilty et al.,
2010).
Silica particles can lead to acute adverse reactions of the lung after inhalation (Rabolli
et al., 2014) and it has been reported that secretion of the pro-inflammatory cytokine
interleukin-1β (IL-1β) is necessary for particle-induced pulmonary inflammation (Yazdi
et al., 2010; Guo et al., 2013). Because of its potent action, IL-1β biogenesis is tightly
regulated. First, an inactive pro-IL-1β precursor is synthesized, which is subsequently
cleaved by the intracellular inflammasome complex (comprising caspase-1 and NLRP3)
to yield biologically active IL-1β for extracellular secretion (Dinarello, 2011; Netea et al.,
2015). The actual trigger of pro-IL-1β induction remains unclear, but in acute lung in-
flammation a case has been made for IL-1α, released mainly from necrotic macrophages,
being a master regulator of pro-IL-1β expression (Rabolli et al., 2014). Another previ-
ous report implicated tumor necrosis factor (TNF)-α as a trigger of pro-IL-1β induction
(Franchi et al., 2009).
SAS particles withstand gastrointestinal digestion (Peters et al., 2012), reach the intesti-
nal mucosa, penetrate through mucus and epithelial barriers and accumulate in underly-
ing tissues (Evans et al., 2002). Consequently, particle aggregates containing silicon are
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detected in the gut-associated lymphoid tissue of humans (Shepherd et al., 1987; Powell
et al., 1996). In addition, silica levels of up to 300 μg g-1 tissue (a value converted from
the actually measured silicon concentration) were found in the spleen of rodents after
repeated oral administration of SAS particles (van der Zande et al., 2014). The intes-
tine is less sensitive to irritation compared with lung, but it has been proposed that a
life-long contact of the gut-associated lymphoid tissue with deposits of exogenous par-
ticles may lead to harmful long-term reactions responsible for chronic inflammatory
diseases of the intestinal tract (Lomer et al., 2002; Hummel et al., 2014). To further ad-
dress this potential hazard, we tested the response of steady-state DCs, representing the
most sensitive sentinels of foreign materials, to two kinds of food-grade SAS particles
and, as comparators, to TiO2 and FePO4 nanoparticles of different sizes. This study
was instigated by the notion that steady-state DCs, in view of their specialized antigen-
presenting function, may respond to nanomaterials by distinctly different mechanisms
than macrophages or other previously tested cell types.
RESULTS
Characterization of particles. Food-grade SAS particles were analyzed in depth to
determine their shape, specific surface area and hydrodynamic diameter. Under the
conditions used for testing of cellular responses, i.e. in cell culture medium, these nanos-
tructured SASmaterials with primary particle diameters of 7 and 13 nm form aggregates
with a mean diameter of 147 and 127 nm, respectively (Table 1). Nanoparticles of TiO2
or FePO4 were included in order to have at hand a range of highly defined probes for the
comparison of DC reactivity towards different nanomaterials. These reference particles
of TiO2 or FePO4 form aggregates ranging in size between 67 and 352 nm. Traceable
100-nm polystyrene (PS) particles were used exclusively as a size standard for hydrody-
namic diameter measurements. Based on a highly sensitive Limulus amoebocyte lysate
assay, all nanomaterials listed in Table 1 were free of endotoxin contamination except a
batch of commercial 50-nm PS particles not used for subsequent biological assays.
Steady-state DCs internalize food-grade nanomaterials. Mouse bone marrow cells
were incubated with Flt3L to generate immature DCs from progenitor cells contained
in these cultures. These Flt3L-generated DCs were maintained in culture flasks or wells
as semi-adherent cell suspensions. The interaction of immature DCs with SAS particles
(displaying a primary particle size of 13 nm), FePO4 particles (with a primary size of 11
nm) andTiO2 particles (with a primary size of 33 nm), suspended in cell culturemedium,
was first monitored by flow cytometry. The resulting side scatter (SSC) reflects internal
cellular structures due to particle uptake whereas the front scatter (FSC) represents cell
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[EU per 250 μg
particles]
7-nm SAS 326 147 (105-193)g 147 ± 5 Irregular LOD
h
13-nm SAS 175 182 (130-241) 127 ± 1 Irregular LOD
11-nm FePO4 188
183 (124-
267) 255 ± 35 Irregular LOD
21-nm FePO4 98
178 (110-
258) 230 ± 40 Irregular 0.006





sured 352 ± 6
Almost
spherical LOD





100-nm PSk Not measured 104 (91-114) Not mea-sured Spherical Not measured
aThe primary particle diameter was calculated from specific surface area and weight (2.6 kg m-3 for SAS,
2.9 kg m-3 for FePO4 and 3.9 kg m-3 for TiO2).
bCalculated from nitrogen adsorption (Micromeritics Tristar 3000) at 77 K and relative pressure range
p/p0 = 0.05-0.25 using the Brunauer-Emmett-Teller (BET) theory.
cDetermined using Nanoparticle Tracking Analysis 2.3 on a NanoSight instrument (Malvern).
dDetermined by dynamic light scattering using a Zetasizer Nano ZS (Malvern). CM, complete cell culture
medium; values are reported as mean ± standard deviation (n = 3).
eDetermined by transmission electron microscopy (TEM).
fDetermined in the Endosafe PTS endotoxin test (Charles River). A control with Escherichia coli LPS at
the concentration of 10 pg ml-1 yielded 0.037 EU ml-1; EU, endotoxin units.
gNumbers in parenthesis show the 10% and 90% probability range.
hLOD, limit of detection (0.005 EU ml-1).
iThis endotoxin finding obtained with a purchased batch of polystyrene (PS) particles is included to show
an example of contaminated commercial material.
kThese 100-nm traceable standard particles from Thermo Scientific served as a size standard for hydrody-
namic diameter measurements by Nanoparticle Tracking Analysis.
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size (Zucker et al., 2010; Wang et al., 2016). Upon incubation with SAS particles, the
proportion of DCs with elevated SSC values was increased in a dose-dependent manner
(Figures 1a-c). In contrast, the front scatter (FSC) remained unchanged when the DCs
Figure 1. Interaction of steady-state DCs with nanomaterials. Flt3L-generated imma-
ture DCs were incubated for 1 h at 37°C with the indicated concentrations of SAS (13-nm
primary diameter), 11-nm FePO4 or 33-nm TiO2 particles, and analyzed by flow cytom-
etry. In culture medium, the SAS particles form aggregates with a mean diameter of 127
nm. The forward scatter (FSC) depends on cell size whereas the side scatter (SSC) reflects
intracellular contents like granules (Zucker et al., 2010; Wang et al., 2016). (a) Flow cytom-
etry distributions demonstrating a SAS dose-dependent increase of DCs with elevated SSC
values. (b) Mean percentage of cells in the selected gate (shown in a) with high SSC val-
ues. Upon one-way ANOVA, SAS treatments increased the proportion of high-SSC cells in
a significant manner (p<0.05, n=4 experiments with independent bone marrow isolates).
Error bars, standard errors of the mean (s.e.m.). (c) Ratios of median SSC. Upon one-way
ANOVA, SSC values after incubation with SAS particles were significantly higher than con-
trols (p<0.05, n=4). (d) Comparison with SSC increments resulting from incubation of
DCs with FePO4 and TiO2 nanoparticles (quantifications are shown in Additional file 1:
Figure S2).
were exposed to SAS particles. Similar responses with elevated SSC and unchanged
FSC were observed upon incubation of DCs with the FePO4 and TiO2 nanoparticles
(Figure 1d, Additional file 1: Figure S2). These findings indicate that immature DCs
readily interact with all three types of nanomaterials.
The interaction of immature DCs with SAS particles was further investigated by trans-
mission electron microscopy (TEM) after high-pressure cryo-fixation to immobilize bi-
ological processes and visualize cellular contents, including membranes, at nanometer
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resolution (Figure 2a). This electron microscopy approach revealed multiple protrud-
ing dendrites on the cell surface (Figure 2b) indicative of actin-dependent uptake mech-
Figure 2. Internalization of nanomaterials by steady-state DCs. Immature DCs were
incubated for 2 h at 37°C with 250 μg ml-1 SAS particles (13-nm primary diameter) and
analyzed by TEM. (a) Typical steady-state DC with emerging dendrites interacting with
particles. N, nucleus; bar, 0.5 μm. Contrasted with uranyl acetate and lead citrate for
15 min; the rectangle indicates the area selected for higher magnification. (b) Magnified
region of the DC near its cell surface showing membrane protrusions (arrowhead) in the
process of engulfing SAS particles (asterisk). The two arrows indicate internalized particles
within a vacuole (V). Scale bar, 0.2 μm. (c) Magnified region of a DC in the process of
engulfing SAS particles (asterisk) into intracellular vacuoles. Scale bar, 0.2 μm; contrasted
with uranyl acetate and lead citrate for 1 min to improve particle visibility. (d) Analysis of
a representative intracellular SAS particle aggregate and cytoplasmic background by energy-
dispersive X-ray spectroscopy (EDX). Internalized FePO4 and TiO2 particles are shown in
Additional file 1: Figure S3.
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anisms (Sallusto et al., 1995; Sarkar et al., 2005). By closure of these membrane protru-
sions, SAS particles become trapped in cytoplasmic membrane-bound vesicles that have
the appearances of endosomes (Figure 2c). Analysis of enclosed particle aggregates by
energy-dispersive X-ray spectroscopy (EDX) on a scanning TEM instrument confirmed
their expected elemental composition, mainly silicon and oxygen (Figure 2d). As a
control, analysis of the cellular background, not containing any SAS particles, revealed
signals of carbon (a normal biological constituent and part of the embedding resin) and
copper (from the TEM specimen support grid). Analogous images showed that im-
mature DCs also internalize FePO4 and TiO2 nanoparticles and, as observed for SAS
particles, localize them to membrane-bound vesicles with the appearance of endosomes
(Additional file 1: Figure S3).
Food-grade SAS causes induction of IL-1β in steady-state DCs. To assess functional
consequences of this nanomaterial uptake into immature DCs, we determined cell via-
bility and secreted cytokine levels as biomarkers of inflammatory reactions. Propidium
iodide staining demonstrated the absence of cytotoxicity when immature DCs were
incubated with SAS particles at concentrations of up to 250 μg ml-1 (Additional file 1:
Figure S4). Despite this lack of cytotoxicity, however, SAS particles initiated IL-1β secre-
tion from immature DCs without any pre-stimulation (usually referred to as ”priming”)
with an inflammatory trigger (Figure 3a). Dose dependence experiments revealed a sig-
nificantly increased IL-1β secretion at a SAS concentration of 100 μg ml-1 (Figure 3b),
corresponding to a surface-related nanomaterial density of 50 μg cm-2. This extracellu-
lar secretion of IL-1β in response to SAS particles took place without any extracellular
release of the cytokines IL-1α (Figure 3c) and TNF-α (Figure 3d).
Since contamination of the SAS batches with endotoxin was excluded by a highly sen-
sitive Limulus amoebocyte lysate test (Table 1), it is concluded that SAS particles are
sufficient to activate immature DCs and induce the release of a potent inflammatory
cytokine. Using small-molecule inhibitors, we next tested whether an intracellular par-
ticle uptake is necessary to induce the observed cytokine release. IL-1β production was
reduced to baseline levels upon co-treatment of DCs with cytochalasin D, which is a
broad inhibitor of actin-dependent processes (Winter et al., 2011), or rottlerin, a selec-
tive inhibitor of macropinocytosis (Additional file 1: Figure S5) (Sarkar et al., 2005).
These inhibitor effects support the conclusion that the IL-1β responses to SAS particles
requires endocytic uptake by actin-mediated mechanisms, primarily macropinocytosis.
In contrast, despite their cellular uptake (Additional file 1: Figure S3), FePO4 and TiO2
nanoparticles elicit no IL-1β response (Figure 3a).
Mechanism of IL-1β induction by SAS particles. Because of its potent inflammatory
action, IL-1β biogenesis is tightly regulated. First, an inactive pro-IL-1β precursor is
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Figure 3. IL-1β secretion induced by food-grade SAS particles. Immature DCs were
incubated (18 h, 37°C) with particles to test for IL-1β secretion. Asterisks denote signif-
icant differences between SAS treatments and controls (*p<0.05, **p<0.01, ***p<0.001,
****p<0.0001). (a) DCs were exposed to particles (250 μg ml-1) and supernatants analyzed
for IL-1β. Control reactions contained medium (CTR), 6 μg ml-1 ODN1668 (mimicking
microbial DNA) or 1 μg ml-1 lipopolysaccharide (LPS). One-way ANOVA with Dunnet’s
correction; n=3–9; error bars, s.e.m. (b)Dose dependence of IL-1β secretion stimulated by
SAS particles. Unpaired two-tailed t-test (n=3–12). (c) Release of IL-1α into the cell culture
supernatant stimulated by LPS (1 μg ml-1) but not by 13-nm SAS particles. Asterisks denote
significant differences between the LPS treatment and controls containing only cell culture
medium (****p<0.0001). Cytokine levels below detection limit (4 pg ml-1) are indicated as
not detectable (nd). One-way ANOVA with Dunnet’s correction; n=4; error bars, s.e.m.
(d) Release of TNF-α into the cell culture supernatant stimulated by LPS (100 ng ml-1) but
not by 13-nm SAS particles. Asterisks denote significant differences between the LPS treat-
ment and controls containing only cell culture medium (****p<0.0001). Cytokine levels
below detection limit (8 pg ml-1) are indicated as not detectable (nd). One-way ANOVA
with Dunnet’s correction; n=4; error bars, s.e.m.
synthesized, which is then cleaved by the intracellular inflammasome complex (involv-
ing caspase-1) to yield biologically active IL-1β (Dinarello, 2011; Netea et al., 2015). In
line with this well-known pathway, the release of IL-1β upon stimulation with SAS
particles was reduced by co-treatment with the caspase inhibitor Z-VAD (Additional
file 1: Figure S5), confirming caspase cleavage of pro-IL-1β. Next, we analyzed whole
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cell lysates for the presence of pro-IL-1β to understand whether this protein precursor
occurs constitutively in immature DCs or is induced following SAS particle uptake. In
incubations of 18 h, SAS particles were able like lipopolysaccharide (LPS) to induce the
de novo production of pro-IL-1β (Figure 4a). Dose dependence experiments revealed a
Figure 4. Induction of pro-IL-1β by food-grade SAS particles. Immature DCs were
incubated (18 h, 37°C) with the indicated concentration of particles to test for pro-IL-1β
induction. Asterisks denote significant differences between SAS treatments and controls
(**p<0.01). (a) DCs were incubated with LPS (250 ng ml-1) or 13-nm SAS and analyzed
for pro-IL-1β (31 kDa) and actin (42 kDa) by immunoblotting. (b) Quantification of pro-
IL-1β induction by SAS particles (unpaired two-tailed t-test, n=5). (c) Incubation of TLR-
2/3/4/7/9-/- DCs with LPS (250 ng ml-1), ODN1668 (600 ng ml-1), medium (CTR) or SAS
particles (125 μg ml-1). (d) Incubation of wildtype DCs with ODN1668 (600 ng ml-1),
medium or particles indicated (125 μg ml-1). (e) Effect of TLR inhibition. DCs were in-
cubated with 13-nm SAS (125 μg ml-1) alone or in the presence of chloroquine and analyzed
for pro-IL-1β and histone H3 (17 kDa) by immunoblotting. ODN1668 (600 ng ml-1) served
as the positive control.
significantly increased pro-IL-1β level at a SAS concentration of 30 μg ml-1 (Figure 4b),
equivalent to a surface-related nanomaterial density of 15 μg cm-2. Pro-IL-1β was also
induced upon SAS treatment of immature DCs lacking Toll-like receptor 4 (TLR4; Ad-
ditional file 1: Figure S6). Pro-IL-1β was equally induced upon SAS treatment of imma-
ture DCs lacking simultaneously TLR2, TLR3, TLR4, TLR7 and TLR9 (Figure 4c). As
these particular pattern recognition receptors mediate DC activation by the most abun-
dant pathogen constituents like endotoxin (TLR2 and TLR4) or nucleic acids (TLR3,
TLR7 andTLR9) (Pandey et al., 2015) the retained pro-IL-1β induction observed in their
absence confirms that this response is not due to microbial contamination. However,
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pro-IL-1β is not induced by FePO4 and TiO2 nanoparticles (Figure 4d). Considering
that the particles are detected in endosomes (Figure 2), the mechanism of pro-IL-1β
induction by SAS was further delineated using endosomal acidification inhibitors. Pro-
IL-1β induction by SAS particles was reduced to baseline levels upon co-treatment with
chloroquine (Figure 4e) or bafilomycin A1 (Additional file 1: Figure S7), which both in-
hibit the endosomal acidification process required for TLR activation (Rutz et al., 2004).
This effect points to an endosomal pattern recognition receptor as the molecular sensor
of SAS particles.
Concomitant display of maturation markers. Immature DCs are distinguishable
from those emerging during inflammation by their molecular phenotype (Dalod et
al., 2014). For example, immature DCs are characterized by low surface expression
of CD69, but the presentation of this maturation marker is increased upon incubation
with SAS particles. CD69 up regulation occurs with both major subsets of steady-state
DCs, i.e., with conventional and plasmacytoid DCs (Figure 5a). Conventional DCs are
Figure 5. Maturation markers on steady-state DCs. Immature DCs were incubated
for 18 h at 37°C with the indicated stimulus and their cell surface markers were analyzed
by flow cytometry. (a) Increased CD69 on the surface of DCs exposed to SAS particles
(13-nm primary diameter) or oligonucleotide ODN1668. Plasmacytoid and conventional
DCs are the two major subsets differing in B220 expression. (b) Representative histograms
showing dose-dependent changes of CD69 and CD40 on conventional DCs exposed to the
indicated stimuli. Control, unstimulated DCs in culture medium. (c) Representative his-
tograms showing dose-dependent changes in the display byCD69, CD40, CD86 andCD62L
on plasmacytoid DCs. (d) Quantification of maturation markers by median fluorescence
intensity (MFI) on plasmacytoid DCs exposed to SAS particles (13-nm primary size). Statis-
tical significance (*p<0.05, **p<0.01, ***p<0.001) was determined by one-way ANOVA
with Dunnet’s correction, n=3 experiments with independent bone marrow isolates; error
bars, s.e.m.
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further characterized by low CD40, which is increased upon exposure to SAS particles
(Figure 5b). Plasmacytoid DCs are further characterized by low CD40/CD86 and high
CD62L, but incubation with SAS particles increased CD40 and CD86 on their surface,
whereas CD62L levels were reduced (Figure 5c and 5d). Thus, in response to SAS par-
ticles, immature DCs not only induce the synthesis of pro-IL-1β but also undergo a
dose-dependent maturation program involving shifts in multiple surface markers. This
finding confirms the ability of SAS particles to activate immature DCs.
DISCUSSION
This study is fundamentally different from earlier reports describing the interaction
of DCs with nanomaterials in two main aspects. First, the ability of nanomaterials
to trigger IL-1β secretion from DCs was previously demonstrated only after priming
these cells with LPS to induce expression of the pro-IL-1β precursor. Consequently,
these previous reports demonstrated that certain nanomaterials are able to activate the
inflammasome, which acts as an enzymatic complex that cleaves preformed pro-IL-1β
to liberate the active IL-1β cytokine (Yazdi et al., 2010; Winter et al., 2011). In contrast
to our present findings, these earlier studies did not report any pro-IL-1β induction
in nanomaterial-exposed DCs. Second, these earlier studies were limited to inflamma-
tory DCs derived from blood or bone marrow cultures stimulated with granulocyte-
macrophage colony-stimulating factor (GM-CSF) (Yazdi et al., 2010; Winter et al., 2011).
However, GM-CSF drives the differentiation of monocytes towards a special DC subset
that sustains inflammation during exceptionally high demand like sepsis (Watowich &
Liu, 2010; Varol et al., 2009; Cheers et al., 1988). These inflammatory DCs differ from
the Flt3L-derived immature DCs used in our study whose function is to maintain tissue
homeostasis by tuning immunologic responses (Watowich & Liu, 2010; Shortman &
Naik, 2007; Xu et al., 2007).
Protective immunity is supported by IL-1β but, if not controlled, this highly inflam-
matory cytokine contributes to autoinflammatory and autoimmune diseases (Dinarello,
2011). Normally, IL-1β production is regulated by two independent signals. A first
stimulus, such as LPS, IL-1α or TNF-α, prompts the synthesis of inactive pro-IL-1β
by transcriptional induction (Rabolli et al., 2014; Franchi et al., 2009). A second stim-
ulus activates the inflammasome resulting in caspase cleavage of pro-IL-1β to release
active IL-1β (Franchi et al., 2009; Yazdi et al., 2010; Winter et al., 2011; Netea et al.,
2015). In an animal model of acute pulmonary inflammation, Rabolli et al. (2014) de-
scribe a sequential mechanism in which lung-injected silica is taken up by macrophages,
thus leading to cytotoxicity. The following release of IL-1α and TNF-α from necrotic
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macrophages serves as a stimulus to induce the expression of pro-IL-1β, which is then
cleaved upon silica-dependent inflammasome activation for the secretion of bioactive
IL-1β (Rabolli et al., 2014). In contrast to this sequential scenario, our analysis with
immature DCs (reflecting steady-state DCs in tissues) revealed for the first time that
SAS particles are able to directly induce pro-IL-1β expression in the absence of cyto-
toxic reactions and any IL-1α or TNF-α bursts. This direct pro-IL-1β induction is not
dependent on the pattern recognition receptors TLR2, TLR3, TLR4, TLR7 and TLR9.
However, we surprisingly observed that the endosomal acidification inhibitors chloro-
quine and bafilomycin A completely abrogate the pro-IL-1β expression induced by SAS
particles. Since the endosomal acidification process – inhibited by these compounds
– is required for TLR activation (Rutz et al., 2004), we conclude that another endoso-
mal pattern recognition receptor must constitute the molecular sensor of SAS particles
responsible for pro-IL-1β induction. This strict and proven dependence on endosomal
acidification also argues against other signaling mechanisms for example associated with
cytotoxicity or increased K+ efflux through the cell membrane (Zhang et al., 2012; Sun
et al., 2015).
Figure 6. The response of Flt3L-generated immature DCs defines SAS as the first com-
plete inflammatory nanomaterial. In steady-state (immature) DCs, the potent inflamma-
tory cytokine IL-1β is not expressed and secretion is highly regulated by two independent
signals. Exposure to food-grade silica causes both pro-IL-1β induction and its cleavage lead-
ing to IL-1β secretion. In addition, immature DCs undergo maturation involving shifts in
multiple surface markers.
In summary, our findings indicate that the nanostructured surface of food-grade SAS
particles, detected by intracellular pattern recognition receptors, mimics both the signal
for inducing pro-IL-1β expression and the signal for activating pro-IL-1β cleavage. This
study with steady-state DCs, therefore, defines SAS as the first complete inflammatory
nanomaterial sufficient for de novo induction of IL-1β without needing any additional
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cytotoxic or inflammatory trigger (Figure 6). The unprecedented single-hit mechanism
of IL-1β induction suggests that SAS particles should be used in food more cautiously
than current practice. Based on studies in rodents not assessing immunological end-
points, a lifelong dietary intake of 1.5 g SAS daily (Additional file 1: Figure S8) per
adult is currently considered safe (reviewed in Ref. (Winkler et al., 2016)). Even if only
a small fraction of the daily ingested SAS materials accumulates over time in lymphoid
tissues (Shepherd et al., 1987; van der Zande et al., 2014; Hummel et al., 2014; Awaad
et al., 2012), these persisting particles are very likely to reach locally in the tissue the
15 μg cm-2 density that in our assays is already sufficient for de novo IL-1β induction in
DCs, without any accompanying cytotoxicity. An ensuing disruption of the gatekeep-
ing function of DCs may trigger long-term inflammatory responses that contribute to
the increased incidence of inflammatory bowel disease or other chronic intestinal disor-
ders (Lomer et al., 2002; Hummel et al., 2014). In view of the unexpected finding that
SAS particles cause IL-1β induction by a novel mechanism, as well as the subsequent
IL-1β release, we advocate a more prudent use of these nanomaterials to reduce human
exposure from food or other sources.
MATERIALS AND METHODS
Particles and Characterization. Food-grade SAS particles, produced by flame hydrol-
ysis according to the Aerosil method (Sepeur et al., 2008), were obtained from Evonik
(formerly Degussa). Their mean primary particle sizes are 7 and 13 nm based on mea-
sured BET surface areas of 326 m2 g-1 and 175 m2 g-1, respectively. These same SAS
particles were also characterized thoroughly by others (Dekkers et al., 2011; Peters et
al., 2012). TiO2 anatase with an average particle size of 33 nm (based on a measured
BET surface area of 47 m2 g-1) were from Sigma-Aldrich. Food-grade TiO2 anatase with
an average particle size of 140 nm (based on a measured BET surface area of 11 m2 g-1)
was from Sachtleben. FePO4 nanoparticles with an average particle size of 11 and 21
nm (based on measured BET surface areas of 188 m2 g-1 and 98 m2 g-1, respectively)
were produced by flame spray pyrolysis (described in the Additional file 1: Supporting
Materials and Methods). Amino-modified PS particles with a primary particle diameter
of 50 nm were obtained from Bangs Laboratories. The detailed characterization of all
nanomaterials is summarized in Table 1.
For endotoxin analyses, particles were suspended in endotoxin-free water (Charles
River) by mixing for 30 s on a vortex followed by sonication for 10 min in a Sonorex
Digitec waterbath (Bandelin Electronic) at 35 kHz and 80 W. Then particle suspensions
were assayed using the Endosafe-PTS test system (Charles River) equipped with highest
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sensitivity cartridges with a limit of detection of 0.005 endotoxin units (EU) ml-1. For
exposure of cells, particles were suspended in complete cell culture medium [RPMI-1640
GlutaMAX, 10% (vol/vol) heat-inactivated fetal calf serum (fromPAA), 100Uml-1 peni-
cillin, 100 µg ml-1 streptomycin and 50 µM β-mercaptoethanol (all from Invitrogen)] by
mixing and sonication as described above. Fresh particle suspensions were prepared for
every experiment and used within 15min after sonication. SAS suspensions in complete
medium remained stable for 24 h, as assessed by hydrodynamic size measurements.
Stimulation of Immature DCs. Immature DCs were generated frommouse bone mar-
row (Naik et al., 2010). Briefly, femurs and tibiae of C57BL/6 wild-type mice (or TLR-
deficient mice on a C57BL/6 background) were flushed with complete culture medium
and the released progenitor cells were filtered through a 70-µm cell strainer (BD Fal-
con), centrifuged, reconstituted in complete medium and incubated for 8 days in the
presence of 200 ng ml-1 Flt3L (BioXcell). For each culture, the amount of live CD11c+
DCs, the proportion of plasmacytoid DCs (CD11c+B220+) and conventional DCs
(CD11c+B220-CD11bhighSIRPα+ and CD11c+ B220-CD11bintermediateSIRPα+) were ver-
ified by flow cytometry (Additional file 1: Figure S1). Stimulation assays were con-
ducted as previously published (Hochrein et al., 2004). Immature DCs, which grow as
cell suspensions, were transferred to 96-well plates (3 x 105 cells/well) containing com-
plete cell culturemedium (200 µl/well) and challengedwith the indicated concentrations
of particles suspended in medium for the time indicated. Realistic SAS particle dose con-
centrations (30 to 250 µg µl1) were derived from a recent publication, where silica levels
of up to 300 μg g-1 tissue in the spleen of rodents after repeated oral administration of
SAS particles were reported (van der Zande et al., 2014).
Control incubations were carried out with ultra-pure lipopolysaccharide (LPS; Es-
cherichia coli 0111:B4, Sigma-Aldrich) or unmethylated deoxyribonucleic acid (DNA)
oligonucleotides containing a CpG motif (ODN1668, TIB Molbiol). The inhibitors
bafilomycin A1 (InvivoGen), cytochalasin D (Enzo Life Sciences), rottlerin (Sigma-Ald-
rich) and Z-VAD-FMK (Bachem) were dissolved in dimethyl sulfoxide and added as in-
dicated. Chloroquine diphosphate salt (Sigma-Aldrich) was added as indicated.
DC Phenotype and Maturation. DCs were stained on ice with conjugated antibod-
ies against CD11c (N418, PE-labeled), CD11b (M1/70, PE-Cy7-labeled), B220 (RA3-
6B2, APC-eFluor 780-labeled), SIRPα (P84, APC-labeled), CD40 (1C10, PE-labeled),
CD62L (MEL-14, APC-labeled), CD69 (H1.2F3, APC-labeled) and CD86 (GL1, PE-
labeled) purchased from eBioscience. A FACSCanto II flow cytometry instrument
(BD Biosciences) was employed to acquire 50000 events. Dead cells were stained and
excluded from analyses using propidium iodide (PI; Sigma-Aldrich). Single-color and
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fluorescence-minus-one (FMO) controls were prepared and analyzed along with multi-
color samples. Flow cytometry datawere analyzedwith FlowJo (Version 10, TreeStar).
Cryo-fixation and Electron Microscopy. Immature DCs were transferred to 12-well
plates (3 x 106 cells/well) containing complete cell culture medium (1 ml/well). After
incubation with particles (250 μg ml-1), cells were prefixed with 0.25% (vol/vol) glu-
taraldehyde and immediately high-pressure frozen in capillary cellulose tubes using an
EMHPM 100 device (Leica). Frozen cells were transferred into a substitution unit (EM-
AFS2, Leica) precooled to –90°C for substitution with acetone containing 5% water.
The subsequent fixation was carried out with 1 % (wt/vol) osmium tetraoxide, 0.25%
(vol/vol) glutaraldehyde raising the temperature to 20°C, then the cells were embedded
in epon. Ultrathin (70 nm) sections were contrasted with uranyl acetate and lead citrate
for 15min (for standard contrast) or 1 min (for improved detection of particles)(Roberts,
2002) and examined in a transmission electron microscope (CM12, Philips) equipped
with a CCD camera (Ultrascan 1000, Gatan) at an acceleration voltage of 100 kV. Ele-
mental analysis of selected samples was conducted on a scanning transmission electron
microscope (G2 Spirit, FEI Tecnai) equipped with a high angle annular dark field de-
tector (HAADF) and an X-Max energy-dispersive X-ray spectroscopy (EDX) detection
system for elemental analysis (Oxford). Gatan digital micrograph was used for image
acquisition and Oxford INCA for EDX operation and control.
Immunoassays. IL-1β concentrations in cell culture supernatants were detected using
the IL-1β DuoSet kit (R&D Systems) following the manufacturer’s instructions. Ab-
sorbance was measured at 405-nm wavelength (reference wavelength 492 nm) with a
SpectraMax Plus 384 microplate reader (Molecular Devices). Mouse IL-1α and TNF−α
-concentrations in cell culture supernatants were detected using the IL-1α and TNF−α
Ready-SET-Go kits (eBioscience) following themanufacturer’s instructions. Absorbance
was measured at 450-nm wavelength (reference wavelength 570 nm) with a Epoch 2 mi-
croplate reader (BioTek). For Western blotting, cells were washed three times with
phosphate-buffered saline (PBS) and whole cell lysates were prepared using M-PER
buffer (LifeTechnologies). Equal volumes of cell lysate were resolved on 4-20% (wt/vol)
polyacrylamide gradient gels (TGX Stainfree) and the separated proteins were trans-
ferred to TurboBlot PVDF membranes (both from BioRad). For immunodetection,
membranes were blocked with 10% (wt/vol) milk in Tris-buffered saline, containing
0.1% (vol/vol) Tween-20, for 1 h at room temperature and probed overnight with anti-
bodies against IL-1β (Cell Signaling) and actin (Millipore). After incubation withmatch-
ing secondary antibodies, chemiluminescence was detected using the ChemiDocMP gel
documentation instrument (BioRad).
Statistical Analysis. Mean and standard error of the mean (s.e.m.) were calculated for
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all quantitative parameters using GraphPad Prism 6.0. Results were expressed as mean
± s.e.m. of multiple determinations with independent DC cultures. Comparisons were
conducted by one-way ANOVA with Dunnet’s correction or unpaired two-tailed t-test,
as indicated in the figure legends. A statistically significant difference was assumed for
p<0.05.
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Figure S1. Characterization of steady-state DCs. 
Immature DCs, generated from mouse bone marrow progenitors in the presence of Flt3L, were 
analyzed by flow cytometry. For each culture, the proportion of live CD11c+ DCs, the proportion 
of plasmacytoid DCs (CD11c+B220+) and the proportion of conventional DCs (CD11c+B220–
CD11bhighSIRPα+ and CD11c+ B220–CD11bintermediateSIRPα-) were verified using the respective 




Figure S2. Interaction of steady-state DCs with FePO4 and TiO2 particles. 
Flt3L-generated immature DCs were incubated for 1 h at 37°C with the indicated concentrations 
of FePO4 (11-nm diameter) or TiO2 particles (33-nm diameter) suspended in cell culture 
medium, and analyzed by flow cytometry. The forward scatter signal (FSC) depends on the size 
of cells whereas the side scatter (SSC) reflects intracellular structures like granules. (A) Ratios of 
median SSC values resulting from incubation of immature DCs with FePO4 relative to controls. 
(B) Ratios of median SSC values obtained from incubation of immature DCs with TiO2 particles 
relative to controls. Upon one-way ANOVA, SSC values resulting from the incubation of 
immature DCs with FePO4 and TiO2 particles were significantly higher than controls (p<0.05,  




Figure S3. Internalization of FePO4 and TiO2 nanoparticles by steady-state DCs. 
Flt3L-generated immature DCs were incubated for 2 h at 37°C with 250 µg ml–1 TiO2 or FePO4 
particles and analyzed by transmission electron microscopy. (A) Typical steady-state DC 
interacting with FePO4 (11-nm primary particle diameter). The arrow indicates internalized 
FePO4 particles within a cytoplasmic membrane defining a vacuole. Scale bar, 0.1 µm. (B) 
Typical steady-state DC interacting with TiO2 (33-nm primary particle diameter). The arrow 
indicates internalized TiO2 particles within a cytoplasmic membrane defining a vacuole. Scale 







Figure S4. Cell viability upon incubation with SAS particles. 
The effect of 13-nm SAS particles on cell viability was analyzed by flow cytometry after 
propidium iodide staining. Flt3L-generated immature DCs were incubated for 18 h at 37°C with 
13-nm SAS particles at the indicated concentrations. Results represent the percentage of viable 
(propidium iodide-negative) cells relative to medium only control. Upon one-way ANOVA, the 
viability values resulting from the incubation of immature DCs with SAS particles were not 
significantly different from controls (one-way ANOVA with Dunnet's correction, n = 5, error 
bars indicate s.e.m.). Please note that a statistically significant pro-IL-1 induction is observed at 





Figure S5. Effect of inhibitors on IL-1 secretion induced by SAS particles. 
Flt3L-generated immature DCs were incubated for 18 h at 37°C with 13-nm SAS (250 µg ml–1) 
alone or in the presence of cytochalasin D (1.5 µg ml–1), rottlerin (1.5 µg ml–1) and Z-VAD (10 
µg ml–1). Results represent fold changes relative to vehicle controls (one-way ANOVA with 






Figure S6. Induction of pro-IL-1 by SAS particles. 
Flt3L-generated immature DCs from wildtype (WT) or TLR4–/– mice were incubated for 18 h at 
37°C with 13-nm SAS (125 µg ml–1) in cell culture medium, and analyzed by immunoblotting. 






Figure S7. Effect of bafilomycin A1 on pro-IL-1 induction by SAS particles. 
Flt3L-generated immature DCs from wildtype mice were incubated for 18 h at 37°C with 13-nm 
SAS (125 µg ml–1) alone or in the presence of bafilomycin A1 (10 or 100 nM), and analyzed by 
immunoblotting for pro-IL-1. Control reactions contained medium alone or 600 ng ml–1 






Figure S8. Safe upper limit of nano-structured SAS particles.  
The 50-ml measuring cylinder contains 1.5 g of a white fluffy powder consisting of hydrophilic 
SAS produced by the Aerosil method. This amount of food-grade SAS material is currently 
considered safe for a 60-kg adult if consumed daily for a lifetime as food additive.1,2 
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Supporting Materials and Methods 
 
Synthesis of FePO4 nanoparticles. FePO4 nanoparticles with an average particle size of 11 and 
21 nm (based on measured BET surface areas of 188 m2 g–1 and 98 m2 g–1, respectively) were 
produced by flame spray pyrolysis according to a published method3 with minor adaptations to 
obtain the desired particle sizes. Iron nitrate nonahydrate (purity ≥ 97.0%, Riedel-de-
Haën/Sigma-Aldrich) and tributyl phosphate (purity 97%; Sigma-Aldrich) were dissolved in a 
1:1 (vol/vol) mixture of ethanol (abs. denat. 2% 2-butanone, Alcosuisse) and 2-ethylhexanoic 
acid (purity ≥ 99%; Sigma-Aldrich) at a total metal concentration of 0.5 mol l–1 or 0.4 mol l–1 for 
21-nm FePO4 and 11-nm FePO4, respectively. This precursor solution was fed at 3 or 7 ml min
–1 
into the FSP spray nozzles by a syringe pump (Lambda, VIT-FIT) and atomized with 5 or 7 l 
min–1 oxygen (pressure drop 1.5 bar). The spray was ignited by a methane/oxygen (2.5 l min–1 
each) ring-shaped flame. Additionally, 5 l min–1 (sheath) O2 was supplied. All gas flow rates 
were regulated by mass flow controllers (Bronkhorst, EL-FLOW). Using a vacuum pump 
(Busch, Mink MM1202 AV), particles were collected on water-cooled teflon membrane-filters 
(BHA Technologies AG) placed at least 65 cm above the burner.  
 
Supplementary references: 
(1)  van Kesteren, P. C. E.; Cubadda, F.; Bouwmeester, H.; van Eijkeren, J. C. H.; Dekkers, S.; 
de Jong, W. H.; Oomen, A. G. Novel Insights into the Risk Assessment of the 
Nanomaterial Synthetic Amorphous Silica, Additive E551, in Food. Nanotoxicology 2015, 
9, 442–452. 
(2)  EFSA 2009. European Food Safety Authority. Scientific Opinion of the Panel on Food 
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3.2 Nanoparticle effects on epithelial cells
This paper describes the effects caused by food-grade FePO4 particles and synthetic
amorphous silica in epithelial cells.
I designed, performed and analyzed the electronmicroscopy experiments and contributed
the matching materials and methods part for the manuscript.
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Iron phosphate nanoparticles for food applications do not induce 
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Nanotechnology offers new opportunities for providing health benefits in foods. Food fortification with 
iron phosphate nanoparticles (FePO  NPs) is a promising new approach to reducing iron deficiency because 
FePO  NPs o i e high ioa aila ilit  ith superior sensory performance in difficult-to-fortify foods. 
However, their safety remains largely untested. We fed rats for 90 days diets containing FePO  NPs at 
doses at which iron sulfate (FeSO ), a commonly-used food fortificant, has been shown to induce adverse 
effects. Feeding did not result in signs of toxicity, including oxidative stress, organ damage, excess iron 
accumulation in organs, or histological changes. These safety data were corroborated by evidence that 
NPs were taken up by human gastrointestinal cell lines without reducing cell viability or inducing oxidative 
stress. Our findings suggest FePO  NPs appear to be as safe for human consumption as FeSO . 
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Reducing particle size of essential minerals to the nanoscale may sharply increase their absorption 
when used as food fortificants and nutritional supplements1-3. However, safety concerns arise for orally 
ingested nanominerals that do not completely dissolve in the stomach and enter the intestines as intact 
nanoparticles (NPs) that may be taken up, distributed to organs and potentially induce adverse effects4,5.  
Conflicting information regarding the potential toxicity of food relevant NPs has so far hampered the 
widespread application of nanotechnology in the food sector.   
Iron deficiency (ID) affects more than two billion people in industrialized and developing 
countries6. Fortifying food by adding iron can be an effective, sustainable and cost-effective strategy to 
combat ID7. Food fortification with iron is challenging because highly bioavailable iron fortificants such as 
FeSO  are chemically reactive and cause unacceptable organoleptic changes, mainly color and taste, in 
foods8. Therefore, i o  o pou ds i solu le i  ate  like FePO , fe i  p ophosphate Fe4(P2O7)3 or 
elemental iron are often used in the food industry. They have less impact on sensory properties but are 
only poorly absorbed8. Reduction of the particle size of such minerals markedly increases their specific 
surface area (SSA) in relation to mass, leading to improved solubility and in vivo bioavailability9,10. Reducing 
iron compounds to the nanoscale further enhances bioavailability while maintaining the low reactivity of 
the original compounds11. Nanostructured iron and iron/zinc compounds produced by flame spray 
pyrolysis (FSP) were shown to have equivalent iron bioavailability as FeSO 1,2 without reacting with the 
food matrix1,12. The fate and biological impact of nanostructured iron in the gastrointestinal tract has not 
yet been thoroughly investigated but is critical for evaluating their safety.  
While there is scarce data regarding adverse biological effects of iron phosphate NPs, there are a 
number of other food relevant NPs that have been shown to induce adverse outcomes after exposure of 
human intestinal cells or experimental animals to food relevant NPs. Food-g ade SiO  a d TiO  NPs are 
internalized by intestinal epithelial cells and persist biologically13-15. They have been shown to induce 
cytotoxicity, DNA damage and oxidative stress in gastrointestinal cells in vitro, however in the absence of 
blood serum16,17. Short-term administration of TiO  NPs to mice led to an accumulation of DNA strand 
breaks in peripheral leukocytes and bone marrow, as well as lipid peroxidation, oxidative DNA lesions, and 
DNA damage in mouse liver18,19. Administration of ZnO NPs by gavage to mice for two weeks led to liver 
injury associated with lipid peroxidation and DNA damage20. Histopathological lesions in liver and kidney, 
and increased levels of inflammatory cytokines in blood, were reported in mice after oral administration 
of Al O  NPs for 13 weeks21. In rats, oral exposure to Ag NPs for 13 weeks caused systemic Ag distribution 
and liver and kidney injury22. In a similar study, silica accumulation in spleen and liver fibrosis, but no other 
adverse effects were observed after administration of SiO  NPs via the diet for 12 weeks23. Due to the lack 
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of larger control compounds in the above mentioned studies, it is unclear whether the observed adverse 
effects were strictly related to the nanoscale size of the particles. No adverse effects were reported, 
however, after gavage e posu e of ats to Fe P O₇ -NPs24 o  Fe O  NPs22. Furthermore, feeding iron 
deficient rats with a diet containing nanosized iron/zinc compounds (  o   g Fe kgˉ¹) for 13 days did 
not result in tissue accumulation of iron1. To our knowledge, however, the consequences of sub-chronic 
exposure to iron NPs incorporated into the diet at dose levels at which non-nanosized iron salts may induce 
adverse outcomes have never been addressed. Such information is crucial to evaluate whether the 
administration of FePO  NPs ia a ealisti  oute of e posu e a  lead to o el ad e se out o es 
attributable to the nanosize of iron fortificants.  
Here we investigate for the first time the responses of human intestinal cell lines to FePO  NPs as 
well as the sub-chronic dietary exposure of rats to FePO  NPs. It was observed that FePO  NPs a  e take  
up by human intestinal cell lines, but did not induce cytotoxicity or oxidative stress. In addition, exposing 
rats to FePO  NPs at the iron dose in standard rodent diets (35 g Fe kgˉ¹ diet)25 or at a dose at which 
FeSO  has ee  sho  to i du e ad e se effe ts (350 g Fe kgˉ¹ diet)26 for 90 days did not result in any 
measurable adverse effects. The safet  of FePO  NPs afte  o al o su ptio  as e aluated i  o pa iso  
to several food grade control compounds. 
Particle characterization 
FePO  NPs were synthesized by FSP; a scalable production process27 for tailor-made particles with 
high SSA and well-defined chemical composition28. FSP-derived FePO  NPs had SSAs of 98 m² gˉ¹ FePO  
98) and 188 m² gˉ¹ FePO  ) as determined by nitrogen absorption. A larger food-grade FePO  
o pou d FePO  27; SSA of 27 m² gˉ¹) was included in this study as a control for the effect of particle 
size. FeSO  is a highly bioavailable iron compound and was introduced to control for iron toxicity. Food 
grade SiO  NPs (SiO  ; SSA of 200 m² gˉ¹ and SiO  ; SSA of 380 m² gˉ¹) were used to control for the 
effect of non-dissolvable NPs. X-ray diffraction (XRD) indicated that all compounds were amorphous 
(Supplementary Fig. 1). FSP-p odu ed FePO  was composed of near-spherical particles in the size range 
10-40 nm (FePO  ) and 5-10 nm (FePO  ), as indicated by transmission electron microscopy (TEM) 
images (Supplementary Fig. 2). The commercial FePO   was composed of larger and irregularly shaped 
particles in the size range 50-200 nm. Assuming dense spherical particles, the calculated primary particle 
size of FePO   would be 77 nm, however, as shown in the TEM images, these assumptions are not valid 
fo  FePO   a d e the efo e do ot efe  to FePO   as NPs. Finally, the SiO  NPs were irregularly 
shaped and appeared to be present as aggregates (Supplementary Fig. 2).  
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In vitro hazard characterization 
We investigated the impact of FSP-produced FePO  NPs on different human gastrointestinal cell 
lines. By comparing responses in cells derived from a human colon adenocarcinoma (HT29) and its mucus-
secreting subclone (HT29-MTX cells),29 we  assessed whether the presence of mucus alters the interactions 
of NPs with the cells. Additionally, we characterized the responses of human colonic epithelial cells 
(HCECs), established from noncancerous tissue that retain characteristics of normal epithelial cells. HCEC 
cells are not tumorigenic, they do not have mutations in hot spot genes and express epithelial as well as 
stem cell markers30,31. In these three human cell models we investigated cellular uptake of FePO  NPs, their 
influence on cell viability and their potential to induce oxidative stress. 
For in vitro evaluation, NPs were dispersed in cell culture media with 10% fetal bovine serum, 
resulting in agglomerates and polydisperse suspensions with average hydrodynamic diameter from 231 to 
615 nm (Supplementary Table 1). Their diameter was unchanged for up to 72 h (Supplementary Fig. 3), 
suggesting that the dispersion protocol was effective and that changes in agglomerate size during 
exposure of cells to NPs suspensions were negligible. Zeta potential was around -11 mV (Supplementary 
Table 1), a common value for various NPs suspended in cell culture media containing serum and related 
to the formation of a protein corona around the NPs32.  
To assess whether the NPs were taken up by the cells, we characterized FePO  NP-treated cells by 
TEM. After exposure to FePO  NPs for 48 h, internalization of NPs in cells was observed in all three cell 
lines (Supplementary Fig. 4). Unlike other studies where NPs were also found freely in the cytoplasm13 or 
even in the nucleus14, the FePO  NPs e e e lusi el  p ese t as large agglomerates and in membrane-
enclosed vesicles. Neither HCECs, HT29 nor HT29-MTX are phagocytic cells, therefore the NPs may be 
taken up through adsorptive endocytosis, a pathway previously hypothesized to be involved in the uptake 
of iron oxide/hydroxide NPs into Caco-2 cells33.  
Since human intestinal cell lines were active in taking up FePO  NPs, their impact on metabolic 
activity and membrane integrity, as well as the potential to induce oxidative stress was characterized. No 
membrane damage or reduction of metabolic activity appeared to be induced by FePO  NPs even at high 
concentrations and exposure times up to 48 h (Supplementary Fig. 5 (24 h), Fig. 1 and Fig.2 (48 h)). 
Exposure of HCECs to FePO   led to significant membrane damage (Fig. 1f) and reduction in metabolic 
activity (Fig. 2f) after 48 h but not after 24 h (Supplementary Fig. 5). All FePO  particles tested in this study 
had the same chemical composition and structure. Thus the sus epti ilit  of HCECs to a ds FePO   
could be related to the different production method, the primary particle size or the agglomerate size. The 
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FSP-produced FePO  NPs had a calculated p i a  dia ete  of   FePO   and 22 nm FePO  ; 
however, once suspended in cell culture medium containing serum, both formed agglomerates with a 
diameter of around 200-  . The la ge  FePO   formed agglomerates in suspension with a diameter 
of 600-700 nm (Supplementary Fig. 3). Since both FSP-produced FePO  NPs had no impact on cell viability, 
it seems unlikely that the primary particle size is of direct relevance. It is well known, however, that 
agglomerate size and density are related to the settling behavior and the effective amount of NPs that 
come in contact with cells34. The larger agglomerates of FePO   may sediment faster in the cell culture 
well, resulting i  a highe  effe ti e o e t atio  of FePO   o pa ed to the FSP-produced NPs with a 
smaller agglomerate size, aggravating their biological impact.  
 
 
Figure 1. Membrane integrity of intestinal cell lines upon exposure to increasing concentrations of FePO₄ 
NPs for 48 h. a-f) Membrane integrity of HT29-MTX, HT29 and HCEC cells after exposure to FePO₄ NPs. 
Cells were exposed to equivalent concentrations of a-c) SiO₂ NPs to control for the effect of non-dissolvable 
NPs (concentrations were standardized on SSA) and to d-f) larger FePO₄ 27 and FeSO₄ concentrations were 
standardized on molar concentrations of Fe). Results are expressed as mean ± s.d. % metabolic activity 
relative to untreated cells. Data are from three independent experiments with three technical replicates. 
Significant differences to untreated control cells were determined with a two way ANOVA and Bonferroni 




A s all edu tio  i  ell ia ilit  as o l  o se ed i  HCECs upo  e posu e to FePO  , ut ot 
in HT29 and HT29-MTX cells. The difference in cellular responses may be related to the fact that HT29 and 
HT29-MTX cells are cancer-derived, while HCECs were established from noncancerous tissue. Previous 
studies have also shown that cancer cells are more resistant to particle-mediated toxicity than non-
malignant cells35. Under the conditions tested, no influence on metabolic activity or membrane integrity 
was observed for any of the cell lines exposed to SiO  NPs. These o se atio s a e i  li e ith p e ious 
studies ega di g the effe t of SiO  NPs o  i testi al ells u de  si ila  e posu e o ditio s13-15. 
 
Figure 2. Metabolic activity of intestinal cell lines upon exposure to increasing concentrations of FePO₄ 
NPs for 48 h. a-f) Metabolic activity of HT29-MTX, HT29 and HCEC cells after exposure to FePO₄ NPs. Cells 
were exposed to equivalent concentrations of a-c) SiO₂ NPs to control for the effect of non-dissolvable NPs 
(concentrations were standardized on SSA) and to d-f) FePO₄ 27 and FeSO₄ concentrations were 
standardized on molar concentrations of Fe). Results are expressed as mean ± s.d. % metabolic activity 
relative to untreated cells. Data are from three independent experiments with three technical replicates. 
Significant differences to untreated control cells were determined with a two way ANOVA and Bonferroni 
correction, P<0.05, and are indicated by *. 
 
Oxidative stress is one of the major mechanisms by which NPs are proposed to damage cells36,37. 
Especially iron containing compounds can catalyze the formation of free radicals via the Fenton and Haber-
Weiss reactions38. We therefore assessed the potential of the FePO  NPs to induce oxidative stress in 
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human cell lines by measuring intracellular levels of glutathione (GSH). The tripeptide GSH is a potent and 
highly abundant free-radical scavenger largely responsible for maintaining cellular redox status and thus 
protecting cells from oxidative damage39. Treatment of the cells with the control compound diethyl 
maleate (DEM), a GSH scavenger, led to a marked reduction in GSH content (Supplementary Fig. 6). Even 
though DEM levels were adjusted for each cell line and exposure time, HCECs died after treatment for 6 
or 24 h and HT29 and HT29-MTX cells after DEM exposure for 24 h. After short-term (2 h and 6 h) or long-
term (24 h) exposure to FePO  NPs and SiO  NPs, no changes in GSH levels were observed in the intestinal 
cell lines (Supplementary Fig. 6) providing no evidence for the induction of oxidative stress.  
During NP-induced oxidative stress, the GSH concentration is expected to decrease, as was 
observed for HepG2, A549 and A431 cells exposed to Fe O  NPs40,41. Similarly to our results, exposure of 
primary rat hepatocytes and IMR-90 ells to Fe O  NPs did not affect GSH levels40. Three and 24 h exposure 
of HT29 cells to 40 and 200 nm SiO  NPs did not induce changes in GSH levels, whereas 24 h exposure of 
HT29 cells to the same SiO  NPs as tested in this study led to a 160 % increase in GSH13. The dose in that 
study was slightly higher (500 µg mlˉ¹), but the cell culture media and the assay to measure GSH were very 
similar to our experiments. The cell confluency during the assay may however explain the observed 
difference. We exposed cells to the NPs in their exponential growth period while in the previous study 
cells were approximately 80% confluent when exposed to the NPs13.  
Dietary NP administration to rats 
We characterized the impact of sub-chronic dietary exposure to FePO  NPs in rats. Weanling 
Sprague-Dawley rats were exposed to FePO  NPs or control compounds (FePO  , FeSO  and SiO  ) 
(Fig. 3a) for 90 days (Supplementary Fig. 7). The compounds were incorporated into the diet to simulate 
the intended route of exposure for food fortification applications. Each compound was delivered at two 
doses, a low (L)  g Fe kgˉ¹ diet  or high (H) dose (350 mg Fe kgˉ¹ diet). The low dose was equal to the 
normal amount of iron in the standard rodent AIN-93G diet.25 The high dose corresponded to the lowest 
observable adverse effect level (LOAEL) of FeSO  previously found after administering FeSO  to rats in the 
drinking water for 1 and 4 months26. The silica diets contained either 35 or 350 mg Si kgˉ¹ diet and 35 mg 




Figure 3. Iron intake during sub-chronic exposure of experimental ani als to diets co tai i g FePO₄ NPs 
and iron concentration in tissue upon sacrifice. a) Compounds used for in vivo study. b) The average iron 
intake kgˉ¹ BW da ˉ¹ (on a log scale) was estimated based on the body weight and food intake. Non visible 
error bars are too small to be seen. BW = body weight, LOAEL = lowest observable adverse effect level of 
FeSO₄ in rats, RDA = Recommended Dietary Allowance for humans. c) Total iron concentration in spleen, 
liver, kidney and heart. n=12 rats per group, e cept FePO₄ L n= . Data points represent mean ± s.d., 
statistical significance was determined with a two way ANOVA and Bonferroni correction, P<0.05. Bars 
without a common letter (a, b, c or d) are statistically different.  
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The test compounds were administered in the diet at constant concentrations of 35 or 350 mg Fe 
kgˉ¹ diet. The body weight of the rats increased from the start of the study (21 days old) until they were 
sacrificed after 90 days of study (111 days old) with no apparent differences amongst the feeding groups 
(Supplementary Fig. 8a). Furthermore, there were no observed differences in food intake amongst groups 
(Supplementary Fig. 8b). By the time of sacrifice after 90 days of study (111 days old), the animals were on 
average 544±50 g, about 150 g heavier than anticipated for 105 days-old Sprague Dawley rats42. This high 
weight may have been due to the free access to food and housing in single cages, reducing physical 
activity43. In terms of food intake and body weight, the average iron intake per kg body weight per day 
ranged from 1.6±0.1 to 5.0±0.1 mg Fe kgˉ¹ body weight da ˉ¹ i  the lo  dose g oups a d f o  16.0±0.3 to 
50.0±1.0 g Fe kgˉ¹ body weight da ˉ¹ in the high dose groups, both decreasing as the animals grew over 
the period of the study (Fig. 3b). At the beginning of the study consumption of iron exceeded the LOAEL 
fo  FeSO   g Fe kgˉ¹ od  eight da ˉ¹) by up to 25 g Fe kgˉ¹ od  eight da ˉ¹ for the high dose. 
After 36 days (mid study) intake was equal to the LOAEL and at the end of the study intake decreased to 
15 mg Fe kgˉ¹ body weight dayˉ¹, 10 g Fe kgˉ¹ od  eight da ˉ¹ lower than the LOAEL. The average iron 
intake was 28.0± .  g Fe kgˉ¹ body weight da ˉ¹, exceeding the previously reported LOAEL by 3 mg Fe 
kgˉ¹ od  eight da ˉ¹. The average iron intake was approximately 100 times higher than the 
recommended dietary allowances (RDA) for humans of .  a d .  g Fe kgˉ¹ body weight da ˉ¹ fo  e  
and women, respectively44.  
Potential accumulation of iron in selected organs was studied by measuring the total iron 
concentration in spleen, liver, kidney and heart upon sacrifice (90 days). The highest iron concentrations 
were found in the spleen, followed by liver, kidney and heart (Fig. 3c). Iron levels in the spleen were 
significantly lower in animals fed FePO  L compared to all other groups. Animals receiving diets 
containing a low dose of iron had significantly lower spleen iron concentrations compared to groups 
receiving the same compound at high dose. Total liver iron concentration was significantly lower in animals 
fed FePO  L compared to all other groups and  all low-dose groups had significantly lower liver iron 
concentrations compared to the group receiving the same compound at high-dose. In the kidney, iron 
concentration for animals fed FePO  L was significantly lower than all high dose groups except those fed 
FePO  H. No significant differences in iron concentrations in the heart were observed amongst groups. 
The lo e  le els of i o  i  the li e  a d splee  of a i als fed FePO  L indicate smaller iron stores in 
these animals, potentially related to the lower bioavailability of iron from larger FePO  particles2. Elevated 
tissue iron concentration in high dose groups confirmed that iron loading through increased dietary iron 
intake leads to iron accumulation in the liver and spleen45. Nevertheless, we did not observe any difference 
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between the groups receiving iron in the form of NPs or FeSO , suggesting that iron derived from NPs is 
stored and deposited in the body like iron from FeSO .  
In animals fed diets containing SiO  NPs, pote tial silicon accumulation was studied by measuring 
total silicon concentration in spleen, liver, kidney and heart upon sacrifice (90 days) (Supplementary Fig. 
9). Silicon concentrations in organs from control animals fed FeSO  L were below the limit of quantification 
. ± .  µg Si gˉ¹ tissue . Lo  tissue levels of silicon were detected in animals fed SiO  NPs, but no 
differences were observed between animals fed SiO  L or SiO  H, indicating that silicon can be taken 
up from diets containing SiO  NPs and can be distributed systemically as was shown previously23.  
To further characterize the iron status of the animals, we measured the number of red blood cells 
(RBCs), hemoglobin (Hb), hematocrit (Hct) mean corpuscular volume (MCV), mean corpuscular 
hemoglobin (MCH), total iron binding capacity (TIBC), plasma iron (PI) and transferrin saturation (TSAT) 
after 45 and 90 days. At both time points, the FePO  NPs groups did not differ from the group receiving 
FeSO  L in any of the measured parameters (Supplementary Table 2) and all hematological parameters 
were within the normal range in all animals. After 45 days, only the group fed FePO  L differed 
significantly from the g oup e ei i g FeSO  L, as noted by significantly decreased Hb, MCV, MCH and TSAT 
levels. Also after 90 days, the levels of Hb, MCV and MCH in the group fed FePO  L were still significantly 
lower compared to the g oup e ei i g FeSO  L. These findings further corroborate the hypothesis that 
iron from FePO   is less bioavailable compared to FeSO  a d the FePO  NPs. 
We assessed the potential of the FePO  a d SiO  NPs to cause systemic or local oxidative stress by 
measuring levels of GSH in RBCs, in the gastrointestinal mucosa and in the liver. All GSH concentrations 
were very similar to previously reported GSH values in healthy rats46-48 and there were no differences in 
GSH concentrations amongst the diet groups (Fig. 4), providing no evidence for induction of oxidative 
stress. We also investigated potential oxidative DNA damage by quantifying -o o- , -dih d o-  -́
deoxyguanosine (8-oxo-dG) in the gastrointestinal mucosa and liver. 8-oxo-dG is one of the most common 
free-radical-induced oxidative DNA lesions, it is highly mutagenic and a biomarker for oxidative stress49. 
Overall, the 8-oxo-dG levels ranged from 17±6 to 23±9 lesions per 10  dG and from 10±6 to 20±11 lesions 
per 10  dG in the liver and the gastrointestinal mucosa, respectively (Fig. 4d).  
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Figure 4. Levels of total glutathione (GSH) and oxidative DNA damage (8-oxo-dG). a) GSH levels in the 
erythrocytes after 45 and 90 days. b) GSH levels in the gastrointestinal mucosa. c) GSH levels in the liver. 
d) Levels of 8-oxo-dG in gastrointestinal mucosa and liver. Bars represent mean ± s.d., statistical 
significance was determined with a two way ANOVA and Bonferroni correction, P<0.05. For a, b and c) 
n=  rats per group, e cept FePO₄ L n= , for d  liver: n=6, gastrointestinal mucosa: n=12 rats per group.  
No differences in 8-oxo-dG levels amongst the treatment groups were observed, providing no evidence 
fo  the i du tio  of o idati e da age  FePO  NPs. These o se atio s a e o siste t ith data f o  a 
study in which si ila l  high FeSO  i takes did not impact lipid peroxidation, activity of superoxide 
dismutase, glutathione peroxidase and glutathione S-transferase in the colonic mucosa of rats50. In 
contrast, administration of similar doses of FeSO  via the diet increased malondialdehyde levels in spleen 
and gut, induced catalase activity in gut tissue, and decreased glutathione S-transferase activity in spleen 
and gut51. However, those rats were already 15 months old in the beginning of the study and older animals 
64 Results
13 
are generall  o e sus epti le to o idati e st ess o pa ed to ou g a i als. I  the ase of FeSO  
administration in the drinking water, similar FeSO  intakes were linked to increased lipid peroxidation and 
reduced GSH levels in the liver and gastrointestinal mucosa of rats26. In the water the iron was most likely 
p ese t as highl  ea ti e Fe ⁺ io s a d thus ausing oxidative stress. Such damages may not occur during 
iron administration in solid food containing chelators that might reduce direct toxicity to gastrointestinal 
mucosa and decrease iron bioavailability52, resulting in lower liver toxicity.   
We further quantified changes in plasma concentrations of alkaline phosphatase (ALP), alanine 
aminotransferase (ALAT), aspartate aminotransferase (ASAT) and ɣ-glutamyl transferase to assess 
potential liver damage. Plasma concentrations of urea, creatinine, and uric acid were quantified to 
estimate potential kidney damage. After 45 and also 90 days, no differences in any of these biomarkers 
among the different diet groups were observed. This suggests FePO  NPs do not induce liver or kidney 
damage (Supplementary Table 3). It was surprising not to find an effect after 45 days because in the high 
dose groups the administered dose as ell a o e  g Fe kgˉ¹ od  eight da ˉ¹, a d ad i ist atio  
of the same amount of iron as FeSO  was reported to increase ALAT, ASAT and ALP levels26. As mentioned 
previously in the context of induction of oxidative stress, this discrepancy might be attributed to the 
administration via drinking water instead of solid food. 
After the sacrifice, histological analysis of organs and tissues was performed and stains for Fe2+ 
and Fe3+ were used to assess iron deposition. All tissues stained negatively for Turnbull blue (for Fe ⁺), 
while mild positive Prussian blue staining (for Fe ⁺) was observed in all tissues except heart, brain and 
testis. The incidence of staining was not influenced by the dose or the composition of the iron compound. 
The only observed difference in the high dose groups compared to the g oup e ei i g FeSO  L was 
increased positive iron staining of enterocytes and in cells (macrophages and fibrocytes) of the lamina 
propria mucosae in the duodenum and the colon (Supplementary Fig. 10 and Supplementary Fig. 11). 
Despite these apparent iron depositions, no abnormal histological changes were detected.  
Conclusions 
Food fortification with highly bioavailable FePO  NPs could play an important role in combatting 
ID, but safety concerns arising from their small size limit their use. We tested the potential of two FePO  
NPs to induce adverse effects both in vivo and in three different gastrointestinal cell lines. The FePO  NPs 
did not induce direct toxicity or oxidative stress in human gastrointestinal cell lines regardless of the 
presence of mucus or the transformational state of the cells. Furthermore, administration of diets enriched 
with FePO  NPs – at a dose recommended for laboratory rodents or at a dose at hi h FeSO  previously 
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induced adverse effects – did not lead to any toxicologically relevant adverse outcomes or accumulation 
of tissue iron. This is the first investigation of the influence of sub-chronic in vivo exposure to FePO  NPs 
and relation with responses of human cells. The data suggest FePO  NPs are at least as safe for human 
consumption as FeSO , e ause ad i ist atio  of FePO  NPs at doses that were approximately 100 times 
higher than the RDA of iron for women did not result in adverse outcomes. Therefore, these FePO  NPs 
and potentially other nanosized minerals should be further explored as food fortificants and supplements.  
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Materials: I o  phosphate a opa ti les ith a spe ifi  su fa e a ea SSA  of   gˉ¹ FePO  ) and 
  gˉ¹  FePO  ) were produced by flame spray pyrolysis (FSP) as previously described1 with some 
adaptatio s. I o  it ate o ah d ate pu it . ≥ . %, Riedel-de-Haën/Sigma-Aldrich), and tributyl 
phosphate (purity 97%; Sigma-Aldrich), were dissolved in a 1:1 mixture by volume of ethanol (denat. 2% 
2-butanone, Alcosuisse) and 2-eth lhe a oi  a id pu it  ≥ %; Sig a-Aldrich) at a total metal 
o e t atio  of .  ol Lˉ¹ o  .  ol Lˉ¹ fo  FePO   and FePO  98, respectively. This precursor solution 
as fed at  o   L i ˉ¹ i to the FSP sp a  ozzles  a s i ge pu p La da, VIT-FIT) and atomized 
by co-flo i g  o   L i ˉ¹ of o ge  pu it  ≥ . %; Pa gas  at . -1.6 bar pressure drop. The spray was 
ignited  a etha e/o ge  .  L i ˉ¹  i g-shaped flame2. Using a vacuum pump (Busch, Mink 
MM1202 AV), product particles were collected on water-cooled Teflon membrane-filters (1TMTF700WHT, 
BHA Technologies AG) placed at least 65 cm above the burner. Ferric phosphate fine powder (no: 
 ith SSA of   gˉ¹ FePO   a d d ied fe ous sulphate FeSO  o: 05480) were 
pu hased f o  D . Paul Loh a  G H. Na ost u tu ed fu ed sili a ith SSA of   gˉ¹ SiO  ) 
a d   gˉ¹ SiO  ) were kindly provided by Evonik Industries (AEROSIL® 200 F and AEROSIL® 380 F, 
Evonik Industries).  
Nanoparticle characterization: SSA as dete i ed  N -adsorption (Micromeritics Tristar 3000, 
Micromeritics Instruments Corp) at 77 K in the relative pressure range p/p0=0.05-0.25 and calculated using 
Brunauer-Emmett-Teller (BET) theory. Assuming dense spherical particles, the particle diameter (dBET) was 
calculated from the measured SSA according to dBET = / ρ·SSA , he e ρ is the solid pa ti le de sit  
FePO * H O= .  g ˉ3)3. The crystallinity of the NP powders was investigated by X-ray diffraction (XRD) 
on a Bruker AXS D8 Advance diffracto ete  ope ati g ith a Cu Kα adiatio . Fo  t a s issio  ele t o  
microscopy (TEM) analysis, the NPs were dispersed in ethanol o  ddH O, deposited on a carbon or 
parlodion foil supported on a copper grid and analyzed on a CM30ST microscope (FEI; LaB6 cathode, 
operated at 300 kV, point resolution∼2 A°) or a CM12 microscope (FEI, operated at an acceleration voltage 
of 100 kV).  
Cell culture: HT29 were obtained from the Leibnitz-Institut DSMZ GmbH (DSMZ ACC299) and HT29-MTX 
cells were purchased from Culture Collections, UK (ECACC 12040401). Both cell lines were maintained in 
Dulbecco's Modified Eagle Medium GlutaMax (DMEM) with 10% Fetal Bovine Serum (FBS) (v/v) plus 100 
U mLˉ¹ Pe i illi  a d  µg mLˉ¹ Streptomycin (DMEM+; all from Gibco, Life Technologies). HCECs were 
obtained from Prof. Jerry Shay (University of Texas Southwestern Medical Center, Dallas, Texas, USA) and 
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cultured under previously reported conditions4. All cell lines were incubated at 37 °C in a humidified 
at osphe e ith % CO . Cell lines were routinely tested for mycoplasma contamination.  
Preparation of nanoparticle suspensions: Stock suspensions of FePO  NPs, SiO  NPs a d FeSO  e e 
prepared eithe  i  ult apu e ate  .  MΩ·  o  i  DMEM+ a d dispe sed  ult aso i  p o essi g i  
a up ho  so i ato  at  kJ Lˉ¹ Ult aso i  P o esso  VCX , So i s & Mate ials I . . The 
hydrodynamic diameter of NPs after ultrasonic processing in ultrapure water or cell culture media was 
determined by dynamic light scattering (DLS) on a Zetasizer Nano ZS (Malvern). For the cell experiments, 
dilutions of the stock suspension were prepared in DMEM+ and used for the experiments without further 
processing. The concentrations were standardized on 1) molar concentrations of Fe for FePO  , FePO  
98 a d FeSO ;  SSA fo  FePO  , FePO  , SiO   and SiO  . 
Nanoparticle uptake: Uptake of FePO  NPs i to HCEC, HT  a d HT -MTX cells was investigated 
qualitatively by TEM. Cells were seeded in 6-well plates (HT29 and HT29-MTX: 500000 cells/well, HCECs: 
30000 cells/well) on carbon coated sapphire disks (Brügger). After 24 h, cells were exposed for 48 h to 
FePO    µg Lˉ¹ , FePO    µg Lˉ¹  a d FePO   .  µg Lˉ¹ . Cells e e ashed th ee ti es 
with PBS and fixed with 2.5% glutaraldehyde in 0.1 M Na/K-phosphate buffer, for 1 hour at 4°C and kept 
overnight in 0.1 M Na/K-phosphate, postfixed with 1% osmium tetroxide in 0.1 M Na/K-phosphate buffer 
for 1h, dehydrated in a series of ethanol starting at 70%, and after transferring into acetone embedded in 
epon followed by polymerization at 60°C for 2.5 days. Sections of 60 to 80 nm thickness sections were 
stained with uranyl acetate and lead citrate as described in5 and examined in a transmission electron 
microscope (CM12, FEI) equipped with a CCD camera (Ultrascan 1000, Gatan) at an acceleration voltage 
of 100 kV. Digital micrograph (Gatan) was used for image acquisition. 
Cell membrane integrity: To determine the extent of damage to the cell membrane, the amount of lactate 
dehydrogenase (LDH) released into the culture supernatant was determined. Cells were seeded in 96-well 
plates (3000 cells/well). After 24 h, cells were exposed to FePO  NPs, SiO  NPs a d FeSO  suspe sio s 
(FePO  , FePO   a d FeSO : . , . ,  a d .  M Fe; FePO  , FePO  , SiO   and SiO  : 
. , . ,  a d .   Lˉ¹ . Afte   h o   h exposure, the LDH release was assessed using the 
C toto i it  Dete tio  Kit fo  LDH Ro he Diag osti s AG  a o di g to the a ufa tu e ’s p oto ol.  µl 
of supernatant were transferred to a new plate containing 100 µL freshly prepared reagent mix. The 
amount of formazan formed was determined by measuring the absorbance at 490 nm. The relative 
membrane integrity was expressed as: 
Membrane integrity (%) = 100 – [(experimental value – low control)/(high control – low control)*100] 
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The low control, which refers to spontaneous LDH release, was determined as the LDH released from 
untreated cells. The high control, which refers to the maximum LDH release, was determined as LDH 
released from cells treated with the surfactant Triton X-100 (2%).  Results are expressed as mean ± s.d. % 
membrane integrity relative to untreated cells. Each experiment was preformed independently three 
times with three technical replicates. Pote tial i te fe e e of NPs a d FeSO  ith the LDH assa  as 
tested according to6 and no interferences were found. 
Metabolic activity: Metabolic activity was assessed with the MTS assay (CellTiter 96® AQueous One 
Solution Cell Proliferation Assay, Promega). Cells were seeded in 96-well plates (2500 cells/well). After 24 
h the cell culture medium was removed and cells were exposed to FePO  NPs, SiO  NPs a d FeSO  
suspensions (FePO  , FePO   a d FeSO : . , . ,  a d .  M Fe; FePO  , FePO  , SiO   
and SiO  : 0.19, 9.5, 19 and 47.5  Lˉ¹ . Afte   h o   h e posu e, MTS d e as added to ea h ell 
and incubated for 4 h. Plates were centrifuged for 10 min at 2000 g to allow NPs to sediment. Then 60 µl 
of the supernatant were transferred to a new plate and absorbance was measured at 490 nm. Triton X-
100 (2%) and untreated cells were used as positive and negative control, respectively. Results are 
expressed as mean ± s.d. % metabolic activity relative to untreated cells. Each experiment was performed 
independently three times with three technical replicates. Interference of the NPs with the monitoring of 
the bioreduction of a tetrazolium salt (MTS; 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-
(4-sulfophenyl)-2H-tet azoliu  to a fo aza  p odu t a    as tested a d no interferences 
were found. 
Glutathione assay: Cells were seeded in 24-well plates (HT29 and HT29-MTX: 350000 cell/well for 2 h and 
6 h exposure, 250000 cells/well for 24 h exposure; HCECs: 300000 cells/well for 2 h and 6 h exposure, 
200000 cells/well for 24 h exposure). After 24 h, cells were exposed to FePO  NPs, SiO  NPs a d FeSO  
suspensions at the highest concentration used in the cell viability assays (FePO  , FePO   a d FeSO : 
2.5 mM Fe; FePO  , FePO  , SiO   and SiO  : .   Lˉ¹ . Diethyl maleate (DEM) treated and 
untreated cells were used as positive and negative control, respectively. After 2 h, 6 h or 24 h, cells were 
collected and GSH concentration was measured by the enzymatic recycling method, as described 
previously7. Protein content was analyzed using the Pie e™ BCA P otein Assay Kit (Thermo Scientific) 
according to the manufa tu e ’s p oto ol. Results are expressed as mean ± s.d. % GSH content relative to 
untreated cells. Each experiment was preformed independently three times and each sample was analyzed 





Ethical approval for animal experiment: The study protocol was approved by the cantonal veterinary 
office of Zurich, Switzerland (authorization no. 26300). 
Study outline: Three week old male Sprague-Dawley rats (n=120) (Charles River) were individually housed 
in stainless steel cages with grid floor in a colony room kept on a 12/12 h light-dark cycle. Twelve animals 
were randomly assigned to each diet group. Randomization was done according to tables with random 
numbers generated in EXCEL (Professional Edition, Microsoft). The number of animals per group was based 
on past similar studies with the same or very similar animal model8-10. Feed and water was provided ad 
libitum throughout the study. Body weight was recorded twice per week. Food intake was recorded at the 
beginning, around the midpoint and before the end of the study, always for a period of 10 days. After 90 
da s, ats e e a aesthetized  CO  i halatio  and blood was drawn by cardiac puncture. The rats were 
euthanized by heart incision. The organs for histopathological analyses (lung, heart, spleen, liver, kidney, 
stomach, pancreas, duodenum, jejunum, ileum, colon, mesenteric lymph node, brain, sternum and testis) 
were excised and immediately placed in 4% buffered formaldehyde.   
Diets: The experimental diets were based on an iron-free AIN-93G purified rodent diet11 fortified with 
either FeSO , FePO  , FePO   or FePO   at t o diffe e t dose le els. The lo e  dose as  g Fe 
kgˉ¹ diet hi h o espo ds to the o al i o  o e t atio  i  the AIN-93G diet11. The high dose was 
aimed to correspond to the LOAEL of FeSO  i  ats a d as set at  g Fe kgˉ¹ diet. The high dose was 
based on a study of Toblli et al.8 where increased oxidative stress and increased plasma levels of 
biomarkers for liver damage were observed i  ats fed  g Fe as FeSO  kgˉ¹ BW dayˉ¹. Assuming an 
a e age food i take of  g da ˉ¹, a od  eight of 310 g (average weight at 10 weeks of age) and a Fe 
concentration of 350 mg Fe kgˉ¹ diet, the daily Fe intake would be 25 mg Fe kgˉ¹ od  eight. To o t ol 
for the effect of non- iodeg ada le NPs, diets o tai i g eithe   g Si kgˉ¹ diet o   g Si kgˉ¹ diet 
were also used. In the sili a diet, the i o  o e t atio  as  g Fe as FeSO  kgˉ¹ diet. All diets e e 
produced by Dyets Inc. and analyzed for their iron content by atomic absorption spectroscopy (AAS) upon 
arrival.  
Blood analysis: At the midpoint and before the sacrifice, a blood sample was drawn from the sublingual 
vein during light anesthesia with isoflurane. Whole blood was collected 1) in a heparinized capillary for 
hematological analysis and 2) on heparin for plasma separation. Plasma was separated by centrifugation 
and erythrocyte pellet and plasma was immediately frozen at -80 °C. The number of red blood cells, 
hemoglobin levels, hematocrit, mean corpuscular volume and mean corpuscular hemoglobin was 
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measured in whole blood using a Scil vet abc hematology analyzer (Scil Animal Care Company). The 
concentrations of alkaline phosphatase, alanine aminotransferase, aspartate aminotransferase, ɣ-
glutamyl transferase, urea, creatinine and uric acid were measured in blood plasma using standard 
enzymatic and colorimetric methods adapted for the Cobas MIRA® autoanalyzer (Hoffman La Roche). 
Plasma iron concentration and total iron binding capacity were measured as described in12. Transferrin 
saturation was calculated as: plasma iron/TIBC*100. Investigator was blinded to the sample group 
allocation. 
Oxidative stress: Total GSH levels in erythrocytes as well as GSH levels in gastrointestinal mucosa and in 
liver samples collected at sacrifice were measured by the enzymatic recycling method, as described 
previously7. Protein content was analyzed using the Pierce™ BCA P otei  Assa  Kit (Thermo Scientific) 
according to the manufa tu e ’s p oto ol. Results fo  GSH in erythrocytes and in gastrointestinal mucosa 
are expressed as µmol GSH gˉ¹ protein while GSH in liver was expressed as µmol GSH gˉ¹ liver. The levels 
of the oxidative DNA lesion 8-oxo-dG in the liver and the gastrointestinal mucosa were quantified 
according to a previous study13 with small adaptations. During the entire sample preparation, 
deferoxamine and butylated hydroxytoluene were added as antioxidants to prevent unwanted formation 
of 8-oxo-dG and further oxidation thereof14. DNA was extracted with the DNA Isolation Kit for Cells and 
Tissues Version 07 (Roche) according to the a ufa tu e ’s protocol except that incubation with 
proteinase K was done for 1 h at 65 °C and incubation with RNase solution was increased to 1 h. After 
protein precipitation, the samples were centrifuged at 4000 g for 30 min. DNA concentration was 
determined by measuring the absorbance at 260 nm with a NanoDrop ND-1000 Spectrophotometer 
The o Fishe  S ie tifi . Befo e h d ol sis,  f ol [¹ N ] -oxo-dG (Cambridge Isotopes laboratories) 
was added to each sample as internal standard. Hydrolysis of 50 µg DNA resulted in a final sample volume 
of 900 µl which was then fractionated chromatographically with HPLC. The HPLC system (Agilent 
Technologies 1200 Series HPLC) was equipped with a Luna C18 (2) 100Å column (4.6 mm   , , 
Phenomenex) for purification of 8-oxo-dG and quantification of dG. Solvents and gradient were as 
previously described13. Retention time of 8-oxo-dG as determined by injection of a standard was around 
23 min. 8-oxo-dG from the samples was collected 2 min before and 2 min after its retention time. Solvents 
from the collected fraction were removed by lyophilization. The sample was resuspended in 16 µL 
ultrapure water and 9.5 µL were injected in a nanoAcquity UPLC (Waters) coupled to a TSQ Vantage triple 
quadrupole mass spectrometer with ESI source (Thermo Scientific) for quantification of 8-oxo-dG and 
[¹ N ] -oxo-dG. An Atlantis dC18 column (300 µm x 150 mm, 3 µm, Waters) was operated with a linear 
gradient from 0% acetonitrile + 0.1% formic acid (B) in water + 0.1% formic acid (A) to 9% B in 15 min, 
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follo ed  a  i ease to % B i   i , at a flo  ate of l/ i . -oxo-dG and the internal standard 
were quantified as previously described13. Investigator was blinded to the sample group allocation. 
Metal content in organs: Iron concentration in the different tissues was measured with AAS after acid-
assisted digestion. Tissue samples were mineralized in a microwave system (Multiwave GO, Anton Paar) 
in the presence of 5 mL nitric acid (65%) and 1 mL hydrogen peroxide. After digestion, samples were 
diluted with water and iron concentration was measured on a SpectrAA-240FS AAS (Varian). Investigator 
was blinded to the sample group allocation. Silica concentrations were measured with ICP-MS following 
acid assisted digestion. Tissue samples were mineralized in a microwave system (Multiwave 3000, Anton 
Paar) in the presence of 5 mL nitric acid (65%) and 2 mL hydrogen peroxide (30%). After digestion, 0.15 mL 
hydrofluoric acid (48%) was added to dissolve silica, samples were further diluted in water and silica 
concentration was measured on an Agilent 7700x ICP-MS.  
Histology: Histological analyses of lung, heart, spleen, liver, kidney, stomach, pancreas, duodenum, 
jejunum, ileum, colon, mesenteric lymph node, brain, sternum and testis were done in six rats of the 
control group (FeSO  L) and in always six animals of the high dose groups (FeSO  H, FePO  27H, FePO  95H, 
FePO  H and SiO  H). For the analysis by light microscopy, tissues were dehydrated with xylene and 
a descending alcohol row, paraffin embedded and stained with haematoxyli /eosi , P ussia  lue fo  Fe ⁺ 
dete tio  a d Tu ull lue fo  Fe ⁺ detection. The histological examination was performed in a blinded 
manner; the boarded pathologist was unaware of the group assignments. 
Statistical analysis: Animal study: Data were processed and analyzed using IBM SPSS Statistics 23 (IBM) 
and EXCEL (Professional Edition, Microsoft). Values in the text are means + s.d.. For each diet group, data 
were tested for normal distribution using the Shapiro-Wilk test. Outliers were removed according to the 
G u s ite ia ith α= . 15. To compare means between the treatment groups, one-way ANOVA with 
Bonferroni post-hoc test was applied to correct for multiple comparisons. Differences were considered 
significant at p<0.05. Cell study: Data was analyzed with Microsoft Excel 2010 and Graph Pad Prism 6. To 
determine significant differences between treatments and controls, one-way ANOVA with Bonferroni 
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Supplementary Fig. 1. a) XRD patterns of FePO₄ , FePO₄  and FePO₄ . b) XRD patterns of SiO₂ 












Supplementary Fig. 3. A e age h d od a ic dia ete  of FePO₄ a d SiO₂ NPs. The a e age dia ete  
of FePO₄ , FePO₄ , FePO₄ , SiO₂  and SiO₂  suspended in DMEM + 10% FBS was measured 
by DLS directly after ultrasonic dispersion and after 24 h, 48 h and 72 h. Data points represent mean ± 






Supplementary Fig. 4. Uptake of FePO₄ NPs i to i testi al cell li es afte   h. a  FePO₄  i  HT -
MTX cells, b) FePO₄  i  HT  cells, c) FePO₄  i  HCECs, d) FePO₄  i  HT -MTX cells, e  FePO₄  
in HT29 cells, f) FePO₄  i  HCECs, g) FePO₄  i  HT -MTX cells, h) FePO₄  i  HT  cells a d i) 








Supplementary Fig. 5. Membrane integrity and metabolic activity of intestinal cell lines upon exposure 
to inc easi g co ce t atio s of FePO₄ NPs for 24 h. a-f) Membrane integrity of HT29-MTX, HT29 and 
HCEC cells afte  e posu e to FePO₄ NPs. As comparison, cells were exposed to equivalent 
concentrations of a-c) SiO₂ NPs (concentrations were standardized on SSA) and to d-f) FePO₄ 27 and 
FeSO₄ co ce t atio s e e sta da dized o  ola  co ce t atio s of Fe . g-l) Metabolic activity of 
HT29-MTX, HT29 and HCEC cells afte  e posu e to FePO₄ NPs. As comparison, cells were exposed to 
equivalent concentrations of a-c) SiO₂ NPs (concentrations were standardized on SSA) and to d-f) FePO₄ 
27 a d FeSO₄ co ce t atio s e e sta da dized o  ola  co ce t atio s of Fe . Results are expressed 
as mean ± SD % metabolic activity relative to untreated cells. Data is from three independent 
experiments with three technical replicates. Significant differences to untreated control cells were 




Supplementary Fig. 6. Le els of total glutathio e i  i testi al cell li es upo  e posu e to FePO₄ NPs. 
a-f) Intracellular GSH concentrations of HT29-MTX, HT  a d HCEC cells afte  e posu e to FePO₄ NPs 
for 2, 6 and 24 h. Cells were also exposed to equal concentrations of a-c) SiO₂ NPs co ce t atio : .  
m²/L) and to d-f) FePO₄  a d FeSO₄ co ce t atio : .  M Fe . Dieth l aleate DEM  as used i  
all experiments as positive control. Results are expressed as mean ± s.d. % metabolic activity relative 
to untreated cells. Data are from three independent experiments with two technical replicates. 
Significant differences to untreated control cells were determined with a two way ANOVA and 






Supplementary Fig. 7. Schematic outline of the sub-chronic exposure study in rats. Animals were fed 
the corresponding diet for 90 days. Blood was sampled at the midpoint and at the end of the study. 






Supplementary Fig. 8. a) Body weight of different treatment groups during the study, data points 
represent mean ± SD. b) Food intake of different treatment groups during the study. Data points 





Supplementary Fig. 9. Total silicon concentration in spleen, liver, kidney and heart of a i als fed SiO₂ 
L a d SiO₂ H. Data points represent mean ± SD. Statistical significance was determined with the 






Supplementary Fig. 10. P ese ce of Fe³⁺ detected by staining with Prussian blue in duodenum of rats 






Supplementary Fig. 11. P ese ce of Fe³⁺ detected by staining with Prussian blue in colon of rats fed a) 
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4 Materials and Methods
Materials and Methods are listed in the paper in section 3.1. An experimental overview
is shown in Figure 1.
Flow cytometry
ELISA/Western blot Electron microscopy, energy
dispersive X-ray spectroscopy
± Particles
Figure 1. Experimental overview Immature DCs were generated from mouse bone mar-
row cultures containing hematopoietic progenitors and stem cells. After eight days of in-
cubation with Flt3L, these cells were incubated with food-grade nanoparticles. DC surface
and maturation markers were monitored by flow cytometry. Pro-inflammatory cytokine
induction and secretion were analyzed by immunoassays (ELISA/western blot). Internal-
ization of particles was analyzed by transmission electron microscopy. Elemental analysis
of the particles in DCs was done by energy dispersive X-ray spectroscopy.
4.1 Generation of steady-state DCs from mouse bone
marrow
All media were stored at 4°C. Mammalian cells were cultured at 37°C and 5% CO2, in
a humified incubator. Cell culture experiments were performed under a sterile hood.
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A modified Neubauer counting chamber and sterile 0.4% trypan blue solution (ICN
Biomedicals) were used to determine the exact number of live cells. Immature DCs were
generated frommouse bone marrow as described (Naik et al., 2010). Briefly, femurs and
tibiae of C57BL/6 mice were flushed with complete culture medium and the released
progenitor cells were filtered through a 70-μm cell strainer (BD Falcon), centrifuged,
reconstituted in complete medium and incubated for 8 days in the presence of 200 ng/ml
Flt3L (BioXcell). For each culture, the amount of live CD11c+ DCs, the proportion
of plasmacytoid DCs (CD11c+B220+) and conventional DCs (CD11c+B220-CD11bhigh
SIRPα+ and CD11c+ B220-CD11bintermediateSIRPα-) were verified by flow cytometry
4.2 Flow cytometry
5 × 10
5 DCs were harvested by centrifugation for 5min at 500 g, washed with two
times with PBS and stained on ice with conjugated antibodies against CD11c (N418, PE-
labeled), CD11b (M1/70, PE-Cy7-labeled), B220 (RA3-6B2, APC-eFluor 780-labeled),
SIRPα (P84, APC-labeled), CD40 (1C10, PE-labeled), CD62L (MEL-14, APC-labeled),
CD69 (H1.2F3, APC-labeled) and CD86 (GL1, PE-labeled) purchased from eBioscience.
A FACSCanto II flow cytometry instrument (BD Biosciences) was employed to acquire
50’000 events. Dead cells were stained and excluded from analyses using propidium
iodide (PI; Sigma-Aldrich). Single-color and fluorescence-minus-one (FMO) controls
were prepared and analyzed along with multi-color samples. Flow cytometry data were
analyzed with FlowJo (Version 10, TreeStar).
4.3 Immunoassays
Immunoassays were performed as described in 3.1. For immunoblots, proteins resolved
by SDS-PAGE were transferred from the polyacrylamide gel onto PVDF membrane
(Biorad) at a current of 25V for 7min. After 1 h incubation in blocking solution (10%
milk in TBST) to avoid unspecific binding, the membrane was incubated over night
with the primary antibody diluted in TBST and 2.5% milk. Afterwards the membrane
was washed 3 x with TBST and incubated for 1 h with the appropriate secondary anti-
body. The membrane was washed again 3 x with TBST, drained and developped with
enhanced chemiluminescence (ECL) solution (Fisher Scientific). Chemiluminenscence
was detected using a ChemiDoc MP documentation system (Biorad).
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4.4 Cryo-fixation and transmission electron microscopy
ImmatureDCswere transferred to 12-well plates (3×106 cells/well) containing complete
cell culture medium (1 ml/well). After incubation with particles (250µg/ml), cells were
prefixed with 0.25% (vol/vol) glutaraldehyde and immediately high-pressure frozen in
capillary cellulose tubes using an EM HPM 100 device (Leica). Frozen cells were trans-
ferred into a substitution unit (EM-AFS2, Leica) precooled to –90°C for substitution
with acetone containing 5% water. The subsequent fixation was carried out with 1%
(wt/vol) osmium tetraoxide, 0.25% (vol/vol) glutaraldehyde raising the temperature to
20°C, then the cells were embedded in epon. Ultrathin (70 nm) sections were contrasted
with uranyl acetate and lead citrate for 15 min (for standard contrast) or 1 min (for im-
proved detection of particles) (Roberts, 2002) and examined in a transmission electron
microscope (CM12, Philips) equipped with a CCD camera (Ultrascan 1000, Gatan) at
an acceleration voltage of 100 kV. Elemental analysis of selected samples was conducted
on a scanning transmission electron microscope (G2 Spirit, FEI Tecnai) equipped with
a high angle annular dark field detector (HAADF) and an X-Max energy-dispersive X-
ray spectroscopy (EDX) detection system for elemental analysis (Oxford). Gatan digital
micrograph was used for image acquisition and Oxford INCA for EDX operation and
control.
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5 Discussion and outlook
The aim of this thesis was to investigate the effects of food-borne nanomaterials on
dendritic cells in-vitro. We thus set out to investigate whether nanoparticles interact
with steady-state dendritic cells and if this interaction leads to functional implications.
Toxicologists often asked, if the SAS particle concentrations used during this thesis
were in a realistic range. While particle concentrations in human Peyer’s patches or
mesenteric lymph nodes are unknown, a sub-chronic feeding study in rats, with re-
peated oral administration of 2500µg/kg SAS per day, detected concentrations up to
300mg/kg SiO2 in the spleen (van der Zande et al., 2014). The high silica concentration
of 2500µg/kg SAS per day is equivalent to the NOAEL used for the risk assessment
of SAS as a food additive for human consumption (UK Food Standards Agency, 2003;
EFSA, 2009). Therefore a range of different particle doses were tested, with the high-
est dose equivalent to the silica concentration found in the speen of rats orally exposed
to SAS particles. This high SAS concentration of 250µg/ml did not induce cytotoxic
effects in-vitro. In addition, in our studies, food-grade SAS particles caused significant
pro-IL-1β-induction in immature dendritic cells already at the lowest concentration used
(30µg/ml).
While conducting electron microscopy experiments with dendritic cells but also with
epithelial cell lines, it became evident that both cell types are able to internalize SAS
and FePO4 particles. A very important difference was their uptake kinetics – internal-
ized particles in dendritic cells could be detected already after two hours of incubation,
while epithelial cells needed 24-48 hours for particle uptake. This cell type specific prop-
erty underscores the biological importance of dendritic cells as sentinels of the immune
system in the Peyer’s patches of the small intestine.
In lung-related studies with alveolar macrophages, no pro-IL-1β-induction could be de-
tected in response to SAS particles without LPS priming (Rabolli et al., 2014). The same
authors report further that pro-IL-1β-induction in the lung is dependent on IL-1α se-
cretion. In contrast, in our studies food-grade SAS particles caused pro-IL-1β-induction
in unprimed immature dendritic cells without concomitant IL-1α secretion (Figure 1).
This points to important organ- and celltype-specific differences, which should be taken
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Figure 1. The response of Flt3L-generated immature DCs defines SAS as the first com-
plete inflammatory nanomaterial. In steady-state (immature) DCs, the potent inflamma-
tory cytokine IL-1β is not expressed and secretion is highly regulated by two independent
signals. Exposure to food-grade silica causes both pro-IL-1β induction and its cleavage lead-
ing to IL-1β secretion. In addition, immature DCs undergo maturation involving shifts in
multiple surface markers.
into account for toxicological risk assessments of food-grade nanomaterials and need fur-
ther investigation on a mechanistic level.
The finding that SAS particles induce pro-IL-1β-induction and IL-1β secretion from
immature DCs has several implications. First, the dose dependent induction of the
highly regulated inflammatory cytokine pro-IL-1β implies the presence of a cellular
receptor for the detection of SAS particles in DCs.
This receptor has to be intracellular and not on the cell surface, as may be concluded
from the observation that inhibition of SAS particle internalization by co-treatment
with cytochalasin D or rottlerin reduces IL-1β secretion to baseline levels. This hy-
pothesis is supported by electron microscopy data, which demonstrated intracellular
localization of SAS particles in endosomes after internalization.
Given that SAS particles are found in the endosome after uptake, it follows that a recep-
tor for monitoring SAS particles would be strategically well placed at the very same loca-
tion. Therefore, inhibition of endosomal acidification was tested, a prerequisite for en-
dosomal detection by pattern recognition receptors such as TLR9. Chloroquinewas pre-
viously shown to inhibit acidification of the endosome and detection of single stranded
DNA by TLR9 (Rutz et al., 2004). Therefore, the next step was to assess the effects of
chloroquine on pro-IL-1β induction. Co-treatment with chloroquine or bafilomycin A1
(another inhibitor of endosomal acidification) reduced pro-IL-1β induction to baseline
levels. This indicates that SAS particles are sensed by an endosomal pattern recognition
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receptor.
Hence, DC deficient for TLR2, TLR3, TLR4, TLR7 and TLR9 were tested for their
ability to induce pro-IL-1β. The observation, that these cells retained the ability to
induce pro-IL-1β upon treatment with SAS particles confirmed that this response was
not due to microbial contamination with endotoxin or DNA but the identification of
the exact receptor remained elusive.
Consequential, activation of a pattern recognition receptor implies that SAS particles
mimic or represent a pathogen-associated microbial pattern (PAMP). This could be due
to the repetitive surface of SAS particles, which are composed of an ordered pattern of
OH– groups (Zhang et al., 2012) and/or the particulate nature of SAS. With a primary
particle size of 10-20 nm SAS particles are in the same size range as non-enveloped small
single-stranded DNA viruses such as parvo- or circoviruses. Therefore it seems likely,
that SAS particles could act as ”cuckoo’s eggs” inside of endosomes. This property
suggests that SAS particles may be used as an adjuvant for fine tuning immunological
response to vaccines.
On the other hand, the reason for evolution and propagation of a particle specific-
sensing mechanism for SAS is of interest. Why did such a mechanism evolve in DCs and
is passed on despite it’s inherent fitness costs such as energy consumption? On the one
hand, particulate sensing could increase the alertness of the immune system in a “dirty”
environment already before detection of a specific pathogen. Because the timely defense
response towards a pathogen is of high importance for immunity, this could lead to faster
and therefore more effective defense reactions. In addition particulate sensing appears
to be involved in fine tuning the immunological response. While immature DCs are
activated by SAS particles, neither pro-IL-1β induction nor IL-1β secretion is triggered
upon internalization of TiO2 or FePO4 nanoparticles. Follwoing this line of thought,
it would be interesting to engineer particles having both the anticaking properties of
silica used as food additive combined with the surface characteristics of TiO2 or FePO4
particles to obtain a less pyrogenic substitue for silica. In addition, it may be worth the
effort to investigate the response of dendritic cells towards aluminosilicate particles used
often as anticaking agent in food in replacement of SAS particles.
Silica (silicone dioxide) has currently the highest production volume of all engineered
nanomaterials worldwide (Yang et al., 2016). Widespread applications in the food indus-
try use synthetic amorphous silica (SAS) as anticaking agent in powdered food products,
as defoaming agent in beverages, as a thickener in pastes or carrier of flavorings (Dekkers
et al., 2011; Peters et al., 2012). After oral uptake, SAS particles withstand gastrointesti-
nal digestion (Peters et al., 2012) and reach the ileal mucosa. In human subjects, intesti-
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nal particle deposits in Peyer’s patches were reported to be composed of the elements
silicon (Si), titanium (Ti) and aluminum (Al) (Shepherd et al., 1987). While particle
concentrations in human Peyer’s patches or mesenteric lymph nodes are unknown, a
sub-chronic feeding study in rats, with repeated oral administration of 2500µg/kg SAS
per day (equivalent to the NOAEL used for the risk assessment of SAS as a food addi-
tive for human consumption (UK Food Standards Agency, 2003; EFSA, 2009)), detected
concentrations up to 300 mg/kg SiO2 in the spleen (van der Zande et al., 2014). This
concentration detected in vivo is about 10 times higher than the dose which induced
significant effects in our in vitro assay. Therefore, effects of SAS on DCs seem likely and
a reduction of SAS-application in food products may be warranted.
Due to the widespread use of silica in food and it’s enormous production volume, our
finding that SAS particles induce pro-IL-1β-induction and IL-1β secretion from imma-
ture DCs might be relevant for consumers, food industry and regulatory authorities.
Highly exposed consumers themselves could reduce their exposure to SAS particles,
avoiding food products which contain high amounts of SAS particles. Where possible,
food industry may reduce SAS-application in products, or consider substitute products
for anticaking or defoaming agents, thickeners or carriers of flavorings. The in-vitro
test with immature DCs developed during this thesis could be used to screen for a suit-
able substitute product. For regulatory authorities our finding could have significant
value, since it identified a new hazard of SAS particles. As mentioned in the previous
paragraph, SAS particles induce significant pro-IL-1β-induction from immature DCs
at concentrations about 10 times lower than those detected in the spleen of rodents
treated with the NOAEL of SAS. Consequently, future risk assessments of SAS parti-
cles for food-products should include an assessment of their effects on local intestinal
immunity including DCs. Finally, inclusion of the in-vitro test with immature DCs
developed during this thesis in planned tiered-testing strategies could benefit the safe
application of food-borne nanomaterials.
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